{"content":"<li class=\"n-box-item date-title\" data-end=\"1556337599\" data-start=\"1556251200\" data-txt=\"Monday, December 23, 2019\">Friday, April 26, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3455086\" data-ts=\"1556314538\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455086-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a> <font color=\"green\">+12.2%</font>. <a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a> <font color=\"green\">+3.6%</font>. <a href='https://seekingalpha.com/symbol/OMF' title='OneMain Holdings, Inc.'>OMF</a> <font color=\"green\">+2.7%</font>. <a href='https://seekingalpha.com/symbol/LAZ' title='Lazard Ltd'>LAZ</a> <font color=\"green\">+1.8%</font>. <a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc.'>AMC</a> <font color=\"green\">+1.6%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/SUM' title='Summit Materials, Inc.'>SUM</a> <font color=\"red\">-5.9%</font>. <a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics AG'>CRSP</a> <font color=\"red\">-2.5%</font>. <a href='https://seekingalpha.com/symbol/SRCI' title='SRC Energy Inc.'>SRCI</a> <font color=\"red\">-1.4%</font><a href='https://seekingalpha.com/symbol/TOCA' title='Tocagen Inc.'>TOCA</a> <font color=\"red\">-1.4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3455086\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$LXRX $MGI $OMF - After Hours Gainers / Losers https://seekingalpha.com/news/3455086-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3455086-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455066\" data-ts=\"1556310644\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455066-weekly-etf-gainers-losers-04-26-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers (04/26/19)</a></h4><ul>     <li><b>Top gainers: </b><a href='https://seekingalpha.com/symbol/CURE' title='Direxion Daily Healthcare Bull 3x Shares ETF'>CURE</a> <font color=\"green\">+10.4%</font>. <a href='https://seekingalpha.com/symbol/PILL' title='Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF'>PILL</a> <font color=\"green\">+9.7%</font>. <a href='https://seekingalpha.com/symbol/LABU' title='Direxion Daily S&P Biotech Bull 3x Shares ETF'>LABU</a> <font color=\"green\">+8.2%</font>. <a href='https://seekingalpha.com/symbol/YANG' title='Direxion Daily FTSE China Bear 3x Shares ETF'>YANG</a> <font color=\"green\">+7.9%</font>. <a href='https://seekingalpha.com/symbol/UBIO' title='ProShares UltraPro NASDAQ Biotechnology ETF'>UBIO</a> <font color=\"green\">+7.1%</font> .</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/USHY' title='iShares Broad USD High Yield Corporate Bond ETF'>USHY</a><font color=\"red\"> -16.3%</font>. <a href='https://seekingalpha.com/symbol/KORU' title='Direxion Daily South Korea Bull 3x Shares ETF'>KORU</a> <font color=\"red\">-10.5%</font>. <a href='https://seekingalpha.com/symbol/CHAU' title='Direxion Daily CSI 300 China A Share Bull 2x Shares ETF'>CHAU</a><font color=\"red\"> -8.9%</font>. <a href='https://seekingalpha.com/symbol/LABD' title='Direxion Daily S&P Biotech Bear 3x Shares ETF'>LABD</a> <font color=\"red\">-8.6%</font>. <a href='https://seekingalpha.com/symbol/ZBIO' title='ProShares UltraPro Short NASDAQ Biotechnology ETF'>ZBIO</a> <font color=\"red\">-7.9%.</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3455066\" data-linked=\"Weekly ETF Gainers / Losers (04/26/19)\" data-tweet=\"$CURE $PILL $LABU - Weekly ETF Gainers / Losers (04/26/19) https://seekingalpha.com/news/3455066-weekly-etf-gainers-losers-04-26-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3455066-weekly-etf-gainers-losers-04-26-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455051\" data-ts=\"1556309485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455051-lexicon-up-17-after-hours-on-zynquista-nod-in-europe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lexicon up 17% after hours on Zynquista nod in Europe</a></h4><ul><li>Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) is up <font color=\"green\">17%</font> after hours in reaction to European Commission <a href=\"https://seekingalpha.com/pr/17490168-zynquista-now-approved-european-union-treatment-adults-type-1-diabetes\" target=\"_blank\">approval </a>of Zynquista (sotagliflozin) as an adjunct to insulin to improve blood sugar control in adults with type 1 diabetes and a body mass index of at least 27 kg/m<sup>2</sup>, considered overweight.</li><li>About a month ago, the FDA <a href=\"https://seekingalpha.com/news/3445177-lexicon-29-percent-fda-rejection-sotagliflozin\" target=\"_blank\">issued a CRL</a> to co-developer Sanofi (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>) in response to its U.S. marketing application.</li></ul><div class=\"tiny-share-widget\" data-id=\"3455051\" data-linked=\"Lexicon up 17% after hours on Zynquista nod in Europe\" data-tweet=\"$LXRX $SNY - Lexicon up 17% after hours on Zynquista nod in Europe https://seekingalpha.com/news/3455051-lexicon-up-17-after-hours-on-zynquista-nod-in-europe?source=tweet\" data-url=\"https://seekingalpha.com/news/3455051-lexicon-up-17-after-hours-on-zynquista-nod-in-europe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455094\" data-ts=\"1556307958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455094-crude-oil-sinks-3-trump-strikes-again-market-was-poised-for-pullback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude oil sinks 3% as Trump strikes again but market was poised for pullback</a></h4><ul><li>Crude oil futures <a href=\"https://finance.yahoo.com/news/oil-heads-longest-weekly-rally-033108118.html\" target=\"_blank\">fell by the most in two months</a> as Pres. Trump said he again pressed OPEC to cut prices and doubts rose about the effect of supply squeezes from Russia and Iran.</li><li>June WTI settled <font color=\"red\">-2.9%</font> to $63.30/bbl and Brent <font color=\"red\">-3%</font> to $72.15/bbl but bounced off earlier lows after <em>WSJ</em> reported OPEC Secretary General Mohammed Barkindo and Saudi energy minister Khalid al-Falih <a href=\"https://www.wsj.com/articles/opec-saudi-officials-havent-spoken-with-trump-about-oil-prices-11556304536\" target=\"_blank\">had not spoken to Trump about cutting prices</a>.</li><li>Crude hit a six-month high earlier this week after the U.S. said it would not renew waivers on imports of Iranian oil and reports of shipments of contaminated Russian oil.</li><li>\"Fears of a supply shock were greatly exaggerated\" after the Russian outage, PVM Oil Associates analyst Stephen Brennock wrote. \"Refineries usually hold ample crude stockpiles to guard against such disruptions. Little wonder then that the initial knee-jerk price reaction petered out.\"</li><li>The market looked ready for a pullback anyway, said Mizuho Securities' Bob Yawger, as \"There were no shorts in the market; everybody was long. That\u2019s when you start to get in a dangerous situation.\"</li><li>The S&amp;P 500 energy sector (<font color=\"red\">-1.3%</font>) is today's worst performer, as tepid quarterly results from Exxon (<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='red'>-2.1%</font>) and Chevron (<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color='red'>-0.7%</font>) add to angst over the sharp downturn in oil prices.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3455094\" data-linked=\"Crude oil sinks 3% as Trump strikes again but market was poised for pullback\" data-tweet=\"$XOM $CVX $USO - Crude oil sinks 3% as Trump strikes again but market was poised for pullback https://seekingalpha.com/news/3455094-crude-oil-sinks-3-trump-strikes-again-market-was-poised-for-pullback?source=tweet\" data-url=\"https://seekingalpha.com/news/3455094-crude-oil-sinks-3-trump-strikes-again-market-was-poised-for-pullback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>95&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455042\" data-ts=\"1556304483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455042-intc-bita-pro-and-type-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">INTC, BITA, PRO and TYPE among tech movers</a></h4><ul><li><strong>Gainers: </strong>PROS Holdings (NYSE:<a href='https://seekingalpha.com/symbol/PRO' title='PROS Holdings, Inc.'>PRO</a>) <font color=\"green\">+9%</font>. MobileIron (NASDAQ:<a href='https://seekingalpha.com/symbol/MOBL' title='MobileIron, Inc.'>MOBL</a>) <font color=\"green\">+9%</font>. VirTra (NASDAQ:<a href='https://seekingalpha.com/symbol/VTSI' title='VirTra, Inc.'>VTSI</a>) <font color=\"green\">+8%</font>. PagerDuty (NYSE:<a href='https://seekingalpha.com/symbol/PD' title='PagerDuty, Inc.'>PD</a>) <font color=\"green\">+7%</font>. HC2 Holdings (NYSE:<a href='https://seekingalpha.com/symbol/HCHC' title='HC2 Holdings, Inc.'>HCHC</a>) <font color=\"green\">+7%</font>.</li> <li><strong>Losers: </strong>Monotype Imaging Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/TYPE' title='Monotype Imaging Holdings Inc.'>TYPE</a>) <font color=\"red\">-15%</font>. Data I/O Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/DAIO' title='Data I/O Corporation'>DAIO</a>) <font color=\"red\">-11%</font>. Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"red\">-11%</font>. Intel Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) <font color=\"red\">-10%</font>. Bitauto Holdings (NYSE:<a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a>) <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3455042\" data-linked=\"INTC, BITA, PRO and TYPE among tech movers\" data-tweet=\"$PRO $MOBL $VTSI - INTC, BITA, PRO and TYPE among tech movers https://seekingalpha.com/news/3455042-intc-bita-pro-and-type-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3455042-intc-bita-pro-and-type-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455041\" data-ts=\"1556304173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455041-apple-discussed-buying-intel-modem-chip-business-wsj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple discussed buying Intel modem chip business - WSJ</a></h4><ul>   <li>Apple (<a href=\"http://seekingalpha.com/symbol/AAPL\" target=\"_blank\">AAPL</a> <font color=\"red\">-0.8%</font>) <a href=\"https://www.wsj.com/articles/apple-discussed-acquiring-intels-smartphone-modem-chip-business-11556303497\" target=\"_blank\">held talks with Intel</a> (<a href=\"http://seekingalpha.com/symbol/INTC\" target=\"_blank\">INTC</a> <font color=\"red\">-10.1%</font>) starting last year about acquiring parts of the latter's smartphone modem chip business, <i>The Wall Street Journal</i> reports.</li>    <li>Those talks started around last summer and only halted recently, around the time Apple reached its multiyear supply agreement with Qualcomm (<a href=\"http://seekingalpha.com/symbol/QCOM\" target=\"_blank\">QCOM</a> <font color=\"green\">+1.8%</font>), according to the report. But it shows Apple warming up to the idea of bigger deals.</li>    <li>And Intel's now exploring strategic alternatives for its modem chips and has hired Goldman Sachs to manage a process that could result in a sale for a few billion dollars. Other than Apple, interested buyers might be Broadcom (<a href=\"http://seekingalpha.com/symbol/AVGO\" target=\"_blank\">AVGO</a> <font color=\"red\">-0.8%</font>), ON Semiconductor (<a href=\"http://seekingalpha.com/symbol/ON\" target=\"_blank\">ON</a> <font color=\"red\">-1.3%</font>), Samsung (<a href='https://seekingalpha.com/symbol/SSNLF' title='Samsung Electronics Co., Ltd.'>OTC:SSNLF</a>) or China's Unisoc Communications.</li>    <li>A sale could mean unloading an Intel business that was losing about $1B per year; Intel said it was abandoning making modems for 5G phones after news of the Apple-Qualcomm settlement.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451766-behind-apples-surprise-settlement-qualcomm\" target=\"_blank\">Behind Apple's surprise settlement with Qualcomm</a> (Apr. 18 2019)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3455041\" data-linked=\"Apple discussed buying Intel modem chip business - WSJ\" data-tweet=\"$SSNLF $AAPL $INTC - Apple discussed buying Intel modem chip business - WSJ https://seekingalpha.com/news/3455041-apple-discussed-buying-intel-modem-chip-business-wsj?source=tweet\" data-url=\"https://seekingalpha.com/news/3455041-apple-discussed-buying-intel-modem-chip-business-wsj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>105&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455040\" data-ts=\"1556303625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BITA\" target=\"_blank\">BITA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455040-bitautominus-9_4-amid-4_1m-share-discounted-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitauto -9.4% amid 4.1M-share discounted offering</a></h4><ul>    <li>Bitauto Holdings (NYSE:<a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a>) has <font color=\"red\">tumbled 9.4%</font> today, and nailed down a six-year low on NYSE, after news that a 4.1M-share block coming from Morgan Stanley would price at $13.95.</li>    <li>Bitauto closed yesterday at $14.65.</li>    <li>Four holders own at least 4.1M shares, Bloomberg notes: Snow Lake Capital, Invesco, Citic, and Cox Enterprises.</li>    <li>Meanwhile, Bitauto just came off a halt for news following its <a href=\"https://seekingalpha.com/pr/17490067-bitauto-provides-clarification-statement-yiche-life\" target=\"_blank\">statement</a> that has no affiliation or relation with Beijing Yiche Life Auto Chain Service, which just received an administrative warning from the People's Bank of China over misconduct.</li>    <li>Bitauto says it intends to seek protection of its intellectual property rights via trademark protection and anti-competition laws in China.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3455040\" data-linked=\"Bitauto -9.4% amid 4.1M-share discounted offering\" data-tweet=\"$BITA - Bitauto -9.4% amid 4.1M-share discounted offering https://seekingalpha.com/news/3455040-bitautominus-9_4-amid-4_1m-share-discounted-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3455040-bitautominus-9_4-amid-4_1m-share-discounted-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455038\" data-ts=\"1556303214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455038-ford-sees-tesla-in-rear-view-mirror\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ford sees Tesla in rear-view mirror</a></h4><ul> <li>Shares of Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) are <font color=\"red\">down 5.20%</font> and traded at a new 52-week low of $233.18 earlier in the session. The busy week for Tesla featured an underwhelming Autonomy Day presentation, soft Q1 earnings and some capitulation by Wall Street bullish-leaning analysts.</li> <li>For what's it worth, Tesla was <a href=\"https://www.cnbc.com/2019/04/26/stocks-making-the-biggest-moves-midday-ford-intel-mattel-more.html\" target=\"_blank\">passed</a> by Ford (<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a> <font color=\"green\">+10.5%</font>) on the market cap list after the Detroit automaker's results in North America impressed investors. If things stay as they are now, it will be the first time since May 2018 that Ford has traded at a higher cap than Tesla.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454562-ford-plus-7-percent-north-america-results-shine\" target=\"_blank\">Ford +7% after North America results shine</a> (April 25)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3455038\" data-linked=\"Ford sees Tesla in rear-view mirror\" data-tweet=\"$TSLA $F - Ford sees Tesla in rear-view mirror https://seekingalpha.com/news/3455038-ford-sees-tesla-in-rear-view-mirror?source=tweet\" data-url=\"https://seekingalpha.com/news/3455038-ford-sees-tesla-in-rear-view-mirror\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>560&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455037\" data-ts=\"1556302779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455037-ad-giants-rise-after-interpublics-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ad giants rise after Interpublic&#39;s beat</a></h4><ul>   <li>The major advertising holding companies are all higher in U.S. trading today after a <a href=\"https://seekingalpha.com/news/3454981-interpublic-group-companies-plus-5_3-percent-post-q1-results\" target=\"_blank\">strong quarter</a> from Interpublic Group (<a href=\"http://seekingalpha.com/symbol/IPG\" target=\"_blank\">IPG</a> <font color=\"green\">+5.2%</font>).</li>    <li><a href='https://seekingalpha.com/symbol/WPP' title='WPP plc'>WPP</a> is <font color=\"green\">up 5.3%</font>, while Omnicom (NYSE:<a href='https://seekingalpha.com/symbol/OMC' title='Omnicom Group Inc.'>OMC</a>) has <font color=\"green\">risen 2%</font> and Publicis Group (<a href='https://seekingalpha.com/symbol/PUBGY' title='Publicis Groupe S.A.'>OTCQX:PUBGY</a>) is <font color=\"green\">up 4.1%</font>. Dentsu (<a href='https://seekingalpha.com/symbol/DNTUF' title='Dentsu Inc.'>OTCPK:DNTUF</a>) is up 2.6% today.</li>    <li>Meanwhile on the WPP front, Bloomberg notes Bain Capital and Apollo (<a href='https://seekingalpha.com/symbol/APO' title='Apollo Global Management, LLC'>APO</a> <font color=\"green\">+1.4%</font>) are among the firms reported to advance in an auction for WPP's Kantar unit, for which WPP may be seeking up to $4.5B.</li>    <li>EQT, Cinven, CVC, Apax and Permira were previously linked to potential bidding for the unit.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3455037\" data-linked=\"Ad giants rise after Interpublic&#39;s beat\" data-tweet=\"$WPP $OMC $PUBGY - Ad giants rise after Interpublic&#39;s beat https://seekingalpha.com/news/3455037-ad-giants-rise-after-interpublics-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3455037-ad-giants-rise-after-interpublics-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455034\" data-ts=\"1556302097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RBBN\" target=\"_blank\">RBBN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455034-ribbonplus-2_1-after-metaswitch-settles-litigation-for-63m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ribbon +2.1% after Metaswitch settles litigation for $63M</a></h4><ul>   <li>Ribbon Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/RBBN' title='Ribbon Communications Inc.'>RBBN</a>) is <font color=\"green\">up 2.1%</font> in today's action after news that it reached a mediation agreement around litigation with Metaswitch networks resulting in a settlement.</li>    <li>Metaswitch has agreed to <a href=\"https://seekingalpha.com/pr/17489157-ribbon-communications-metaswitch-reach-agreement-resolving-lawsuits\" target=\"_blank\">pay Ribbon $63M</a>: cash payments of $37.5M in Q2, and $25.5M payable in three annual installments starting in 2020.</li>    <li>The installment payments will accrue interest at 4%/year.</li>    <li>The settlement also have the companies cross-licensing all the respective patents globally.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3455034\" data-linked=\"Ribbon +2.1% after Metaswitch settles litigation for $63M\" data-tweet=\"$RBBN - Ribbon +2.1% after Metaswitch settles litigation for $63M https://seekingalpha.com/news/3455034-ribbonplus-2_1-after-metaswitch-settles-litigation-for-63m?source=tweet\" data-url=\"https://seekingalpha.com/news/3455034-ribbonplus-2_1-after-metaswitch-settles-litigation-for-63m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455033\" data-ts=\"1556301712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455033-westwater-resources-and-forum-energy-technologies-among-energy-materials-gainers-newpark\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westwater Resources and Forum Energy Technologies among Energy/Materials gainers; Newpark Resources and and SandRidge Permian Trust among losers</a></h4><ul><li><b>Gainers: </b>Westwater Resources. (NASDAQ:<a href='https://seekingalpha.com/symbol/WWR' title='Westwater Resources, Inc.'>WWR</a>) <font color=\"green\">+16%</font>. Forum Energy Technologies (NYSE:<a href='https://seekingalpha.com/symbol/FET' title='Forum Energy Technologies, Inc.'>FET</a>) <font color=\"green\">+13%</font>. McEwen Mining (NYSE:<a href='https://seekingalpha.com/symbol/MUX' title='McEwen Mining Inc.'>MUX</a>) <font color=\"green\">+10%</font>. MAG Silver (NYSEMKT:<a href='https://seekingalpha.com/symbol/MAG' title='MAG Silver Corp.'>MAG</a>) <font color=\"green\">+9%</font>. Alexco Resource (NYSEMKT:<a href='https://seekingalpha.com/symbol/AXU' title='Alexco Resource Corp.'>AXU</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Newpark Resources (NYSE:<a href='https://seekingalpha.com/symbol/NR' title='Newpark Resources, Inc.'>NR</a>) <font color=\"red\">-12%</font>. SandRidge Permian Trust (NYSE:<a href='https://seekingalpha.com/symbol/PER' title='SandRidge Permian Trust'>PER</a>) <font color=\"red\">-11%</font>. HighPoint Resources (NYSE:<a href='https://seekingalpha.com/symbol/HPR' title='HighPoint Resources Corporation'>HPR</a>) <font color=\"red\">-10%</font>. Rosehill Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/ROSE' title='Rosehill Resources Inc.'>ROSE</a>) <font color=\"red\">-8%</font>. Extraction Oil &amp; Gas (NASDAQ:<a href='https://seekingalpha.com/symbol/XOG' title='Extraction Oil & Gas, Inc.'>XOG</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3455033\" data-linked=\"Westwater Resources and Forum Energy Technologies among Energy/Materials gainers; Newpark Resources and and SandRidge Permian Trust among losers\" data-tweet=\"$WWR $FET $MUX - Westwater Resources and Forum Energy Technologies among Energy/Materials gainers; Newpark Resources and and SandRidge Permian Trust among losers https://seekingalpha.com/news/3455033-westwater-resources-and-forum-energy-technologies-among-energy-materials-gainers-newpark?source=tweet\" data-url=\"https://seekingalpha.com/news/3455033-westwater-resources-and-forum-energy-technologies-among-energy-materials-gainers-newpark\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455031\" data-ts=\"1556301332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455031-naspers-ctrip-exchange-shares-to-invest-in-makemytrip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Naspers, Ctrip exchange shares to invest in MakeMyTrip</a></h4><ul>   <li>A <a href=\"https://seekingalpha.com/pr/17489473-ctrip-announces-share-exchange-transaction-naspers\" target=\"_blank\">share exchange</a> between China's Ctrip.com (<a href=\"http://seekingalpha.com/symbol/CTRP\" target=\"_blank\">CTRP</a> <font color=\"green\">+1.5%</font>) and South Africa's Naspers (<a href=\"http://seekingalpha.com/symbol/NPSNY\" target=\"_blank\">NPSNY</a> <font color=\"green\">+1.3%</font>) has spurred a big move in India-based travel site MakeMyTrip (<a href=\"http://seekingalpha.com/symbol/MMYT\" target=\"_blank\">MMYT</a> <font color=\"green\">+7.6%</font>) today.</li>    <li>Naspers will exchange its stake in MakeMyTrip for newly issued shares of Ctrip; concurrently, Ctrip will invest certain ordinary shares and class B shares of MakeMyTrip in a third-party investment entity.</li>    <li>That will leave Naspers with about a 5.6% stake in Ctrip, and the third-party investment entity will hold ordinary shares and class B shares making up 49% and 4% of MakeMyTrip voting power respectively.</li>    <li>\"We have worked with Ctrip in the past years and are excited to take this partnership to the next level,\" says MakeMyTrip's Rajesh Magow. \"We will leverage this investment to benefit from the tremendous growth potential in travel and tourism between our two countries.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3455031\" data-linked=\"Naspers, Ctrip exchange shares to invest in MakeMyTrip\" data-tweet=\"$TCOM $NPSNY $MMYT - Naspers, Ctrip exchange shares to invest in MakeMyTrip https://seekingalpha.com/news/3455031-naspers-ctrip-exchange-shares-to-invest-in-makemytrip?source=tweet\" data-url=\"https://seekingalpha.com/news/3455031-naspers-ctrip-exchange-shares-to-invest-in-makemytrip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455028\" data-ts=\"1556301285\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/B\" target=\"_blank\">B</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455028-barnesplus-3-on-beating-q1-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes +3% on beating Q1 estimates</a></h4><ul><li>Barnes (<a href='https://seekingalpha.com/symbol/B' title='Barnes Group Inc.'>B</a> <font color=\"green\">+3.4%</font>) reported sales of $377M (+2.7% Y/Y), reflecting acquisition sales of + 5% and organic sales increase of 1% Y/Y.</li><li>Sales by segments: Industrial $21.5M (-33.6% Y/Y); and Aerospace $29.15M (+20.2% Y/Y).</li><li>Aerospace OEM backlog was at $804M (+10% Y/Y), Company expects to ship ~50% of this backlog over the next 12 months.</li><li>Q1 operating margin <font color=\"red\">declined by 200 bps</font> to 13.5%; and Adj. operating margin <font color=\"red\">declined by 90 bps</font> to 14.5%.</li><li>Segment operating margins: Industrial 8.9%<font color=\"red\"> down by 480 bps</font>; and Aerospace 21.7% <font color=\"green\">up by 160 bps</font>.</li><li>SG&amp;A expenses were $81.4M (+11.7% Y/Y); and as percentage of sales 21.6% up by 173 bps.</li><li>Net cash provided by operating activities in the quarter was $53.06M (+74.1% Y/Y).</li><li>Board of Directors authorized repurchase of up to 5M shares of Barnes Group common stock, adding 3.5M shares to the remaining 1.5M shares under the 2016 Stock Repurchase Authorization.</li><li><strong>FY19 Outlook:</strong> Revenue growth 4% to 6%; organic sales growth 1% to 3%; Adj. operating margin 15.5% to 16%; EPS $3.15 to $3.27 (prior $3.17 to $3.32); Adj. EPS $3.23 to $3.35; Capex $60M to $65M; and effective tax rate of 23.5%-24.5%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454748-barnes-group-beats-0_02-beats-revenue\" target=\"_blank\">Barnes Group beats by $0.02, beats on revenue</a> (April 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3455028\" data-linked=\"Barnes +3% on beating Q1 estimates\" data-tweet=\"$B - Barnes +3% on beating Q1 estimates https://seekingalpha.com/news/3455028-barnesplus-3-on-beating-q1-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3455028-barnesplus-3-on-beating-q1-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455023\" data-ts=\"1556299269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIMC\" target=\"_blank\">AIMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455023-altra-industrial-motion-jumps-9-on-q1-results-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altra Industrial Motion jumps 9% on Q1 results beat</a></h4><ul><li>Altra Industrial Motion (<a href='https://seekingalpha.com/symbol/AIMC' title='Altra Industrial Motion Corp.'>AIMC</a> <font color=\"green\">+9.4%</font>) reported Q1 sales growth of 100.8% Y/Y to $482.8M, driven by Automation &amp; Specialty Platform<em> </em>sales, and organic sales growth of 1.6% Y/Y.</li><li>Sales by segments: Power Transmission Technologies $234.9M (-2.3% Y/Y); and Automation &amp; Specialty $249.1M.</li><li>Q1 Gross margin <font color=\"green\">improved by 536 bps</font> to 36.2%; operating margin <font color=\"green\">improved by 556 bps</font> to 13.8%; and Adj. operating margin<font color=\"green\"> improved by 630 bps</font> to 18.2%.</li><li>Adj. EBITDA was $105M; and as percentage of sales 21.7%.</li><li>Net cash provided by operating activities for the quarter was $39.3M, compare to $3.7M a year ago; and free cash flow was  $25.3M.</li><li><strong>FY19 Outlook, reaffirmed:</strong> Sales $1.92B to $1.95B; EPS $2.10 to $2.18; Adj. EPS $3.02 to $3.18; and Adj. EBITDA $415M to $430M. Company expects tax rate of ~24%, Capex of $60M to $65M, and depreciation and amortization $130M to $140M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3453676-altra-holdings-declares-0_17-dividend\" target=\"_blank\">Altra Holdings declares $0.17 dividend</a> (April 24)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454791-altra-holdings-beats-0_08-beats-revenue\" target=\"_blank\">Altra Holdings beats by $0.08, beats on revenue</a> (April 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3455023\" data-linked=\"Altra Industrial Motion jumps 9% on Q1 results beat\" data-tweet=\"$AIMC - Altra Industrial Motion jumps 9% on Q1 results beat https://seekingalpha.com/news/3455023-altra-industrial-motion-jumps-9-on-q1-results-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3455023-altra-industrial-motion-jumps-9-on-q1-results-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455020\" data-ts=\"1556298637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455020-meta-financial-leads-financial-gainers-360-finance-and-federated-investors-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meta Financial leads financial gainers; 360 Finance and Federated Investors among losers</a></h4><ul><li><b>Gainers:</b> Meta Financial Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CASH' title='Meta Financial Group, Inc.'>CASH</a>) <font color=\"green\">+15%</font>. MoneyGram International (NASDAQ:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) <font color=\"green\">+14%</font>. Enova International (NYSE:<a href='https://seekingalpha.com/symbol/ENVA' title='Enova International, Inc.'>ENVA</a>) <font color=\"green\">+13%</font>. The Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/TBBK' title='The Bancorp, Inc.'>TBBK</a>) <font color=\"green\">+12%</font>. Live Oak Bancshares (NASDAQ:<a href='https://seekingalpha.com/symbol/LOB' title='Live Oak Bancshares, Inc.'>LOB</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers:</b> Texas Pacific Land Trust (NYSE:<a href='https://seekingalpha.com/symbol/TPL' title='Texas Pacific Land Trust'>TPL</a>) <font color=\"red\">-8%</font>. Dragon Victory International (NASDAQ:<a href='https://seekingalpha.com/symbol/LYL' title='Dragon Victory International Limited'>LYL</a>) <font color=\"red\">-7%</font>. Federated Investors (NYSE:<a href='https://seekingalpha.com/symbol/FII' title='Federated Investors, Inc.'>FII</a>) <font color=\"red\">-7%</font>. 360 Finance, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/QFIN' title='360 Finance, Inc.'>QFIN</a>) <font color=\"red\">-6%</font>. Jupai Holdings (NYSE:<a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings Limited'>JP</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3455020\" data-linked=\"Meta Financial leads financial gainers; 360 Finance and Federated Investors among losers\" data-tweet=\"$CASH $MGI $ENVA - Meta Financial leads financial gainers; 360 Finance and Federated Investors among losers https://seekingalpha.com/news/3455020-meta-financial-leads-financial-gainers-360-finance-and-federated-investors-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3455020-meta-financial-leads-financial-gainers-360-finance-and-federated-investors-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455017\" data-ts=\"1556298370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBIX\" target=\"_blank\">NBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455017-neurocrine-slips-3-on-express-scripts-exclusion-of-ingrezza\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neurocrine slips 3% on Express Scripts exclusion of Ingrezza</a></h4><ul><li>Neurocrine Biosciences (<a href='https://seekingalpha.com/symbol/NBIX' title='Neurocrine Biosciences, Inc.'>NBIX</a> <font color=\"red\">-3.2%</font>) is down on almost triple normal volume in apparent response to Express Scripts' planned exclusion of tardive dyskinesia med <a href=\"https://www.ingrezza.com/\" target=\"_blank\">Ingrezza</a> (valbenazine), its sole marketed product in the U.S., from its formulary effective July 1.</li><li>The pharmacy benefit manager has apparently opted for the combination of Teva Pharmaceutical Industries' (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"green\">+0.3%</font>) <a href=\"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208082s000lbl.pdf\" target=\"_blank\">Austedo</a> (deutetrabenazine) and tetrabenazine.</li><li>Ingrezza accounted for 99% of NBIX's Q4 revenue of $131.5M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3455017\" data-linked=\"Neurocrine slips 3% on Express Scripts exclusion of Ingrezza\" data-tweet=\"$NBIX $TEVA - Neurocrine slips 3% on Express Scripts exclusion of Ingrezza https://seekingalpha.com/news/3455017-neurocrine-slips-3-on-express-scripts-exclusion-of-ingrezza?source=tweet\" data-url=\"https://seekingalpha.com/news/3455017-neurocrine-slips-3-on-express-scripts-exclusion-of-ingrezza\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455016\" data-ts=\"1556298270\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGI\" target=\"_blank\">MGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455016-buyers-binge-on-moneygram\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buyers binge on MoneyGram</a></h4><ul> <li>MoneyGram International (NASDAQ:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) is <font color=\"green\">up 13.5%</font> on a volume spike and was showing a gain of over 20% earlier in the day. Shares of MGI have been up every day this week.</li> <li>There isn't any specific news to link directly to the buying action.</li> <li>MoneyGram is expected to report earnings around May 6.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3455016\" data-linked=\"Buyers binge on MoneyGram\" data-tweet=\"$MGI - Buyers binge on MoneyGram https://seekingalpha.com/news/3455016-buyers-binge-on-moneygram?source=tweet\" data-url=\"https://seekingalpha.com/news/3455016-buyers-binge-on-moneygram\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455014\" data-ts=\"1556298096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455014-highpower-international-and-granite-construction-among-industrial-gainers-briggs-stratton\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Highpower International and Granite Construction among industrial gainers; Briggs &amp; Stratton leads the losers</a></h4><ul><li><b>Gainers: </b>Altra Industrial Motion (NASDAQ:<a href='https://seekingalpha.com/symbol/AIMC' title='Altra Industrial Motion Corp.'>AIMC</a>) <font color=\"green\">+9%</font>. Highpower International (NASDAQ:<a href='https://seekingalpha.com/symbol/HPJ' title='Highpower International, Inc.'>HPJ</a>) <font color=\"green\">+9%</font>. Innovative Solutions and Support (NASDAQ:<a href='https://seekingalpha.com/symbol/ISSC' title='Innovative Solutions and Support, Inc.'>ISSC</a>) <font color=\"green\">+8%</font>. Attis Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/ATIS' title='Attis Industries, Inc.'>ATIS</a>) <font color=\"green\">+6%</font>. Granite Construction (NYSE:<a href='https://seekingalpha.com/symbol/GVA' title='Granite Construction Incorporated'>GVA</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Briggs &amp; Stratton (NYSE:<a href='https://seekingalpha.com/symbol/BGG' title='Briggs & Stratton Corporation'>BGG</a>) <font color=\"red\">-12%</font>. Astrotech (NASDAQ:<a href='https://seekingalpha.com/symbol/ASTC' title='Astrotech Corporation'>ASTC</a>) <font color=\"red\">-7%</font>. Jason Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/JASN' title='Jason Industries, Inc.'>JASN</a>) <font color=\"red\">-6%</font>. MICT (NASDAQ:<a href='https://seekingalpha.com/symbol/MICT' title='MICT, Inc.'>MICT</a>) <font color=\"red\">-6%</font>. DMC Global (NASDAQ:<a href='https://seekingalpha.com/symbol/BOOM' title='DMC Global Inc.'>BOOM</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3455014\" data-linked=\"Highpower International and Granite Construction among industrial gainers; Briggs &amp; Stratton leads the losers\" data-tweet=\"$AIMC $HPJ $ISSC - Highpower International and Granite Construction among industrial gainers; Briggs &amp; Stratton leads the losers https://seekingalpha.com/news/3455014-highpower-international-and-granite-construction-among-industrial-gainers-briggs-stratton?source=tweet\" data-url=\"https://seekingalpha.com/news/3455014-highpower-international-and-granite-construction-among-industrial-gainers-briggs-stratton\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455011\" data-ts=\"1556297586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455011-intc-rgen-bgg-and-hele-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">INTC, RGEN, BGG and HELE among midday movers</a></h4><ul><li><strong>Gainers: </strong>Aratana Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics, Inc.'>PETX</a>) <font color=\"green\">+37%</font>. India Globalization Capital (NYSEMKT:<a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc.'>IGC</a>) <font color=\"green\">+30%</font>. Regional Health Properties (NYSEMKT:<a href='https://seekingalpha.com/symbol/RHE' title='Regional Health Properties, Inc.'>RHE</a>) <font color=\"green\">+32%</font>. Helen of Troy (NASDAQ:<a href='https://seekingalpha.com/symbol/HELE' title='Helen of Troy Limited'>HELE</a>) <font color=\"green\">+21%</font>. Sonic Automotive (NYSE:<a href='https://seekingalpha.com/symbol/SAH' title='Sonic Automotive, Inc.'>SAH</a>) <font color=\"green\">+15%</font>. Repligen (NASDAQ:<a href='https://seekingalpha.com/symbol/RGEN' title='Repligen Corporation'>RGEN</a>) <font color=\"green\">+15%</font>. IMV (NASDAQ:<a href='https://seekingalpha.com/symbol/IMV' title='IMV Inc.'>IMV</a>) <font color=\"green\">+15%</font>. Meta Financial Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CASH' title='Meta Financial Group, Inc.'>CASH</a>) <font color=\"green\">+14%</font>. Enova International (NYSE:<a href='https://seekingalpha.com/symbol/ENVA' title='Enova International, Inc.'>ENVA</a>) <font color=\"green\">+13%</font>. MoneyGram International (NASDAQ:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers: </strong>Monotype Imaging Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/TYPE' title='Monotype Imaging Holdings Inc.'>TYPE</a>) <font color=\"red\">-15%</font>. Ra Medical Systems (NYSE:<a href='https://seekingalpha.com/symbol/RMED' title='Ra Medical Systems, Inc.'>RMED</a>) <font color=\"red\">-13%</font>. Briggs &amp; Stratton (NYSE:<a href='https://seekingalpha.com/symbol/BGG' title='Briggs & Stratton Corporation'>BGG</a>) <font color=\"red\">-12%</font>. Town Sports International Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CLUB' title='Town Sports International Holdings, Inc.'>CLUB</a>) <font color=\"red\">-12%</font>. Newpark Resources (NYSE:<a href='https://seekingalpha.com/symbol/NR' title='Newpark Resources, Inc.'>NR</a>) <font color=\"red\">-11%</font>. A10 Networks (NYSE:<a href='https://seekingalpha.com/symbol/ATEN' title='A10 Networks, Inc.'>ATEN</a>) <font color=\"red\">-11%</font>. Data I/O Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/DAIO' title='Data I/O Corporation'>DAIO</a>) <font color=\"red\">-11%</font>. Intel Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) <font color=\"red\">-10%</font>. SandRidge Permian Trust (NYSE:<a href='https://seekingalpha.com/symbol/PER' title='SandRidge Permian Trust'>PER</a>) <font color=\"red\">-10%</font>. Diffusion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DFFN' title='Diffusion Pharmaceuticals Inc.'>DFFN</a>) <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3455011\" data-linked=\"INTC, RGEN, BGG and HELE among midday movers\" data-tweet=\"$PETX $IGC $RHE - INTC, RGEN, BGG and HELE among midday movers https://seekingalpha.com/news/3455011-intc-rgen-bgg-and-hele-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3455011-intc-rgen-bgg-and-hele-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455008\" data-ts=\"1556296791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNE\" target=\"_blank\">SNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455008-sony-up-8-surprise-profit-despite-slowdown-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sony up 8% with surprise profit despite slowdown warning</a></h4><ul>   <li>Sony (NYSE:<a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a>) is <font color=\"green\">up 8%</font>, a top gainer today after beating earnings expectations with a bounce back to profit, despite warning of a slowdown ahead and pulling several projections out of uncertainty.</li>    <li>Demand for games were a lift this quarter at least, as well as a gain in its stake in Spotify, and strength in semiconductors, offset somewhat by continuing woes in mobile phones.</li>    <li>It swung to a profit of ¥87.9B (about $787M) vs. a year-ago loss of ¥13.3B, on revenues that rose 9% to ¥2.13T.</li>    <li>But the company expects a sharp drop in annual profits, and the upcoming end of the PlayStation 4 life cycle looks like it may sting.</li>    <li>Sony pulled medium-term profit targets for its electronics and entertainment units out of uncertainty. It had just set those targets less than a year ago.</li>    <li>Considering a major music acquisition, ongoing losses in mobile, and big growth in game software, \"we thought that perhaps it would be a bit misleading to discuss only the 2020 fiscal year,\u201d says CFO Hiroki Totoki.</li>    <li>Sony expects gaming operating profits will fall by 10% for the fiscal year. And while its Xperia phone business lost ¥41.1B this quarter, it's merging with the other electronics businesses, in a unit now projected for an operating profit of ¥121B this fiscal year (up 58%).</li>    <li><a href=\"https://seekingalpha.com/article/4257034-sony-corporation-2018-q4-results-earnings-call-slides\" target=\"_blank\">Earnings call slides</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3454724-sony-beats-41_94-beats-revenue\" target=\"_blank\">Sony beats by ¥41.94, beats on revenue</a> (Apr. 26 2019)</li>    <li><a href=\"https://www.sony.net/SonyInfo/IR/library/presen/er/pdf/18q4_sony.pdf\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3455008\" data-linked=\"Sony up 8% with surprise profit despite slowdown warning\" data-tweet=\"$SNE - Sony up 8% with surprise profit despite slowdown warning https://seekingalpha.com/news/3455008-sony-up-8-surprise-profit-despite-slowdown-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3455008-sony-up-8-surprise-profit-despite-slowdown-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455005\" data-ts=\"1556296740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOOM\" target=\"_blank\">BOOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455005-dmc-global-down-4-despite-q1-results-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DMC Global down 4% despite Q1 results beat</a></h4><ul><li>DMC Global (<a href='https://seekingalpha.com/symbol/BOOM' title='DMC Global Inc.'>BOOM</a> <font color=\"red\">-4.8%</font>) reported Q1 revenue growth of 48.8% Y/Y to $100.13M, driven by continued strong customer demand for intrinsically safe integrated switch-detonators and Factory-Assembled, Performance-Assured\u2122 well perforating systems.</li><li>DynaEnergetics results: Sales $79.84M (+63% Y/Y); gross margin of 39.1% <font color=\"red\">down by 90 bps</font>; and Adj. EBITDA of $24.51M (+83% Y/Y).</li><li>NobelClad results: Sales $20.3M (+12% Y/Y); gross margin 26.4% <font color=\"green\">up by 890 bps</font>; and Adj. EBITDA of $2.71M (+185% Y/Y).12-month book-to-bill ratio was 1.02 and order backlog was $40.5M.</li><li>Q1 Gross margin <font color=\"green\">expanded 244 bps </font>to 36.4%; and operating margin<font color=\"green\"> improved by 1,253 bps </font>to 20.4%.</li><li>Adj. EBITDA increased by 105.3% Y/Y to $23.89M; and margin <font color=\"green\">improved by 657 bps</font> to 23.9%.</li><li>SG&amp;A expenses were $6.31M (+21.1% Y/Y); and as % of sales 6.3% down by 144 bps.</li><li>Net cash provided by operating activities was $6.99M, compare to cash used $2.98M a year ago.</li><li><strong>2Q19 Guidance:</strong> Sales $102M to $107M; Gross margin in range of 35%; SG&amp;A expenses ~$16.5M; and Adj. EBITDA $22M to $24.5M.</li><li><strong>FY19 Guidance:</strong> Sales $405M to $425M; Gross margin ~34%; SG&amp;A ~$63M; effective tax rate ~30%; Adj. EBITDA $90M to $100M; Adj. EPS $3.40 to $3.70; and Capex $25M to $30M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454457-dmc-global-beats-0_28-beats-revenue\" target=\"_blank\">DMC Global beats by $0.28, beats on revenue</a> (April 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3455005\" data-linked=\"DMC Global down 4% despite Q1 results beat\" data-tweet=\"$BOOM - DMC Global down 4% despite Q1 results beat https://seekingalpha.com/news/3455005-dmc-global-down-4-despite-q1-results-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3455005-dmc-global-down-4-despite-q1-results-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3455002\" data-ts=\"1556296022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIT\" target=\"_blank\">AIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3455002-applied-industrial-technologiesminus-4_5-due-to-weak-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied Industrial Technologies -4.5% due to weak margins</a></h4><ul><li>Applied Industrial Technologies (<a href='https://seekingalpha.com/symbol/AIT' title='Applied Industrial Technologies, Inc.'>AIT</a> <font color=\"red\">-4.5%</font>) reports <a href=\"https://seekingalpha.com/pr/17489490-applied-industrial-technologies-reports-fiscal-2019-third-quarter-results\" target=\"_blank\">Q3</a> revenue growth of 7% Y/Y to $885.4M, up 2.3% on an organic daily basis.</li><li>Q3 overall margins: Gross profit <font color=\"red\">declined 7 bps</font> to 28.9%; operating income <font color=\"red\">declined 291 bps</font> to 3.9% and EBITDA <font color=\"green\">increased 56 bps</font> to 9.3%.</li><li>The Company\u2019s increased the quarterly cash dividend to $0.31/common share payable on May 31, 2019.</li><li>\u201cWe continue to take appropriate business and cost actions in Western Canada, and remain encouraged by positive momentum within our U.S. oil &amp; gas end markets where our scaling position in key basins is contributing nicely to our multi-faceted growth.\u201d said Neil A. Schrimsher, Applied\u2019s President &amp; CEO.</li><li><b>2019 Revised Guidance:</b> Adj. EPS $4.50-4.60 on a sales increase of 14-15% Y/Y, or 3%-4% on an organic daily basis.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454904-applied-industrial-technologies-declares-0_31-dividend\" target=\"_blank\">Applied Industrial Technologies declares $0.31 dividend</a> (Apr. 26 2019)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454747-applied-industrial-technologies-misses-0_02-misses-revenue\" target=\"_blank\">Applied Industrial Technologies misses by $0.02, misses on revenue</a> (Apr. 26 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3455002\" data-linked=\"Applied Industrial Technologies -4.5% due to weak margins\" data-tweet=\"$AIT - Applied Industrial Technologies -4.5% due to weak margins https://seekingalpha.com/news/3455002-applied-industrial-technologiesminus-4_5-due-to-weak-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3455002-applied-industrial-technologiesminus-4_5-due-to-weak-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454990\" data-ts=\"1556294598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRSN\" target=\"_blank\">VRSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454990-verisignplus-6-on-q1-beats-registration-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verisign +6% on Q1 beats, registration growth</a></h4><ul><li>Verisign (NASDAQ:<a href='https://seekingalpha.com/symbol/VRSN' title='VeriSign, Inc.'>VRSN</a>) <font color=\"green\">gains 6.2%</font> on yesterday's Q1 beats with .com and .net name registrations in the domain name base up 4.4% Y/Y and name registration processing rose 0.2M on the year to 9.8M.</li><li>The company narrows its FY19 revenue forecast from $1.215-1.235B to $1.220-1.235B (consensus: $1.23B) and reaffirms operating margin from 67.5% to 68.5%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454990\" data-linked=\"Verisign +6% on Q1 beats, registration growth\" data-tweet=\"$VRSN - Verisign +6% on Q1 beats, registration growth https://seekingalpha.com/news/3454990-verisignplus-6-on-q1-beats-registration-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3454990-verisignplus-6-on-q1-beats-registration-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454987\" data-ts=\"1556294529\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454987-ford-motor-and-sony-among-consumer-gainers-davidstea-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ford Motor and Sony among consumer gainers; DAVIDsTEA leads the losers</a></h4><ul><li><b>Gainers: </b>Helen of Troy (NASDAQ:<a href='https://seekingalpha.com/symbol/HELE' title='Helen of Troy Limited'>HELE</a>) <font color=\"green\">+23%</font>. Ford Motor (NYSE:<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a>) <font color=\"green\">+10%</font>. Viomi Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/VIOT' title='Viomi Technology Co., Ltd'>VIOT</a>) <font color=\"green\">+8%</font>. Revlon (NYSE:<a href='https://seekingalpha.com/symbol/REV' title='Revlon, Inc.'>REV</a>) <font color=\"green\">+8%</font>. Sony (NYSE:<a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>DAVIDsTEA (NASDAQ:<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDsTEA Inc.'>DTEA</a>) <font color=\"red\">-7%</font>. Ballantyne Strong (NYSEMKT:<a href='https://seekingalpha.com/symbol/BTN' title='Ballantyne Strong, Inc'>BTN</a>) <font color=\"red\">-6%</font>. New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454987\" data-linked=\"Ford Motor and Sony among consumer gainers; DAVIDsTEA leads the losers\" data-tweet=\"$HELE $F $VIOT - Ford Motor and Sony among consumer gainers; DAVIDsTEA leads the losers https://seekingalpha.com/news/3454987-ford-motor-and-sony-among-consumer-gainers-davidstea-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3454987-ford-motor-and-sony-among-consumer-gainers-davidstea-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454981\" data-ts=\"1556293923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPG\" target=\"_blank\">IPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454981-interpublic-group-of-companiesplus-5_3-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interpublic Group of Companies +5.3% post Q1 results</a></h4><ul><li>Interpublic Group of Companies (<a href='https://seekingalpha.com/symbol/IPG' title='The Interpublic Group of Companies, Inc.'>IPG</a> <font color=\"green\">+5.3%</font>) reports <a href=\"https://seekingalpha.com/pr/17489529-interpublic-announces-first-quarter-2019-results\" target=\"_blank\">Q1</a> revenue growth of 13% Y/Y to $2B, with strong organic net revenue growth of 6.4%.</li><li>Adj. EBITA margin <font color=\"green\">increased 268 bps</font> to 5.17%.</li><li>Operating margin <font color=\"green\">increased 31 bps</font> to 2.5% .</li><li>Organic net increase of 5.7% in the U.S. and 7.7% internationally, attributable to a combination of net client wins and net higher spending from existing clients.</li><li>The company declared and paid a common stock cash dividend of $0.235/share, for a total of $90.6M.</li><li>Cash and  equivalents totaled $630.5M with total debt of $3.94B.</li><li>\u201cWe remain on track to deliver on our targets of organic growth of 2% to 3% and 40-50 bps of improvement to our adj. EBITA margin for the full year.\" said Michael  Roth, Interpublic's Chairman and CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454779-interpublic-group-companies-beats-0_06-beats-revenue\" target=\"_blank\">Interpublic Group of Companies beats by $0.06, beats on revenue</a> (Apr. 26 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454981\" data-linked=\"Interpublic Group of Companies +5.3% post Q1 results\" data-tweet=\"$IPG - Interpublic Group of Companies +5.3% post Q1 results https://seekingalpha.com/news/3454981-interpublic-group-of-companiesplus-5_3-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3454981-interpublic-group-of-companiesplus-5_3-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454980\" data-ts=\"1556293287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMO\" target=\"_blank\">IMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454980-imperial-oil-cuts-full-year-capex-production-curtailment-weighs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Imperial Oil cuts full-year capex as production curtailment weighs</a></h4><ul><li>Imperial Oil (<a href='https://seekingalpha.com/symbol/IMO' title='Imperial Oil Limited'>IMO</a> <font color='red'>-2.9%</font>) slips after missing estimates for both <a href=\"https://seekingalpha.com/news/3454860-imperial-oil-beats-0_04-beats-revenue\" target=\"_blank\">Q1 earnings</a> and revenues while also <a href=\"https://www.reuters.com/article/us-imperial-oil-results/imperial-oil-quarterly-profit-falls-43-percent-cuts-2019-capex-idUSKCN1S219J\" target=\"_blank\">cutting its 2019 spending outlook</a>.</li><li>IMO says it now plans to spend C$1.8B-C$1.9B this year, down from its previous guidance of C$2.3B-C$2.4B, in the wake of production cuts enforced by Alberta's provincial government and weak refining margins.</li><li>\"Alberta's production curtailment order significantly affected financial performance, as improved upstream realizations were more than offset by reduced downstream margins,\" IMO CFO Rich Kruger said.</li><li>Q1 refinery throughput fell 6% Y/Y to 383K bbl/day from 408,000 bbl/day a year ago, while upstream production rose 5% to 388K boe/day from 370K boe/day in the year-ago quarter.</li><li>Cash flow generated from operating activities totaled C$1B vs. C$985M in the year-ago quarter, reflecting higher working capital effects and partially offset by lower earnings.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454980\" data-linked=\"Imperial Oil cuts full-year capex as production curtailment weighs\" data-tweet=\"$IMO - Imperial Oil cuts full-year capex as production curtailment weighs https://seekingalpha.com/news/3454980-imperial-oil-cuts-full-year-capex-production-curtailment-weighs?source=tweet\" data-url=\"https://seekingalpha.com/news/3454980-imperial-oil-cuts-full-year-capex-production-curtailment-weighs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454978\" data-ts=\"1556292965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIX\" target=\"_blank\">FIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454978-on-comfort-systems-q1-results-shares-down-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Comfort Systems Q1 results; shares down ~4%</a></h4><ul><li>Comfort Systems (<a href='https://seekingalpha.com/symbol/FIX' title='Comfort Systems USA, Inc.'>FIX</a> <font color=\"red\">-4.9%</font>) reported Q1 revenue growth of 15.8% Y/Y to $538.47M.</li><li>Q1 Gross margin <font color=\"green\">improved by 66 bps</font> to 19.8%; and operating margin<font color=\"green\"> improved by 106 bps</font> to 5.2%.</li><li>Adj. EBITDA increased by 36.1% Y/Y to $38.48M; and margin <font color=\"green\">improved by 107 bps</font> 7.2%.</li><li>SG&amp;A expenses were $78.91M (+12.7% Y/Y); as percentage of sales 14.7%, down by 41 bps.</li><li>Cash provided by operating activities was $991k, compared to $3.85M a year ago.</li><li>For the Quarter company reported negative Free cash flow of $7.5M, compared to negative $1.4M in 2018.</li><li>Backlog as of March 31, 2019 was $1.14B as compared to $1.08B a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454570-comfort-systems-beats-0_01-revenue-line\" target=\"_blank\">Comfort Systems beats by $0.01,  revenue in-line</a> (April 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454567-comfort-systems-declares-0_10-dividend\" target=\"_blank\">Comfort Systems declares $0.10 dividend</a> (April 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454978\" data-linked=\"More on Comfort Systems Q1 results; shares down ~4%\" data-tweet=\"$FIX - More on Comfort Systems Q1 results; shares down ~4% https://seekingalpha.com/news/3454978-on-comfort-systems-q1-results-shares-down-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3454978-on-comfort-systems-q1-results-shares-down-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454970\" data-ts=\"1556292555\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REGN\" target=\"_blank\">REGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454970-regeneron-slips-2-on-conditional-approval-recommendation-in-europe-for-libtayo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regeneron slips 2% on conditional approval recommendation in Europe for Libtayo</a></h4><ul><li>The European Medicines Agency's advisory group CHMP has adopted a <a href=\"https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-libtayo_en.pdf\" target=\"_blank\">positive opinion</a> backing conditional approval for Regeneron Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color=\"red\">-2%</font>) Libtayo (cemiplimab) for the treatment of advanced cutaneous squamous cell carcinoma, the second most-common type of skin cancer.</li><li>Conditional approval means that the committee has determined that the benefits of availability outweigh the risks but additional data are still required.</li><li>A final decision from the European Commission usually takes ~60 days.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454970\" data-linked=\"Regeneron slips 2% on conditional approval recommendation in Europe for Libtayo\" data-tweet=\"$REGN - Regeneron slips 2% on conditional approval recommendation in Europe for Libtayo https://seekingalpha.com/news/3454970-regeneron-slips-2-on-conditional-approval-recommendation-in-europe-for-libtayo?source=tweet\" data-url=\"https://seekingalpha.com/news/3454970-regeneron-slips-2-on-conditional-approval-recommendation-in-europe-for-libtayo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454971\" data-ts=\"1556292524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVEO\" target=\"_blank\">CVEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454971-civeominus-3_7-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Civeo -3.7% post Q1 results</a></h4><ul><li>Civeo (<a href='https://seekingalpha.com/symbol/CVEO' title='Civeo Corporation'>CVEO</a> <font color=\"red\">-3.7%</font>) reports <a href=\"https://seekingalpha.com/pr/17489464-civeo-reports-first-quarter-2019-results\" target=\"_blank\">Q1</a> sales increase 6.9% Y/Y to $108.6M of which, Canada $66.8M, Australia $28.4M &amp; US of $13.4M.</li><li>Segment adj. EBITDA margin: Total <font color=\"green\">increased 479 bps</font> to 14.6%, Canada <font color=\"green\">increased 123 bps</font> to 15.3%, Australia <font color=\"green\">increased 260 bps</font> to 34.9% and US was 20.9%.</li><li>Also, expanded our Sitka Lodge in British Columbia to 754 rooms during the quarter with 1,100 total rooms expected to be on site by June 2019.</li><li>The company had total liquidity of ~$66M, consisting of $58M available under its revolving credit facilities and $8M of cash on hand.</li><li>Total debt outstanding was $383.5M and invested $9.7M in capex.</li><li><b>Q2 Outlook:</b> Revenues of $113-118M, with EBITDA of $21-23.5M</li><li><b>2019 Outlook:</b> Revenues of $475-485M; with EBITDA of $95M-101M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454727-cveo-misses-0_02-beats-revenue\" target=\"_blank\">CVEO misses by $0.02, beats on revenue</a> (Apr. 26 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454971\" data-linked=\"Civeo -3.7% post Q1 results\" data-tweet=\"$CVEO - Civeo -3.7% post Q1 results https://seekingalpha.com/news/3454971-civeominus-3_7-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3454971-civeominus-3_7-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454969\" data-ts=\"1556292365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454969-volatile-trading-continues-on-new-age-beverages\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volatile trading continues on New Age Beverages</a></h4><ul> <li>New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) is <font color=\"red\">down 4.72%</font> as shares retreat from two days of gains off of Marley distribution and CBD product news.</li> <li>Volume on NBEV has been elevated all week.</li> <li>New Age Beverages trade very close to the midpoint of its 52-week range.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3453554-new-age-beverages-inks-deal-bob-marleys-family\" target=\"_blank\">New Age Beverages inks deal with Bob Marley's family</a> (April 24)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454233-new-age-beverage-plus-10-percent-cbd-portfolio-introduction\" target=\"_blank\">New Age Beverage +10% after CBD portfolio introduction</a> (April 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3454969\" data-linked=\"Volatile trading continues on New Age Beverages\" data-tweet=\"$NBEV - Volatile trading continues on New Age Beverages https://seekingalpha.com/news/3454969-volatile-trading-continues-on-new-age-beverages?source=tweet\" data-url=\"https://seekingalpha.com/news/3454969-volatile-trading-continues-on-new-age-beverages\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454965\" data-ts=\"1556291950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVO\" target=\"_blank\">NVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454965-european-advisory-group-backs-novos-esperoct-for-hemophilia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European advisory group backs Novo&#39;s Esperoct for hemophilia A</a></h4><ul><li>The European Medicines Agency's advisory group CHMP has adopted a <a href=\"https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-esperoct_en.pdf\" target=\"_blank\">positive opinion</a> recommending approval for Novo Nordisk's (<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color=\"green\">+0.9%</font>) Esperoct (turoctocog alfa pegol) for the treatment and prophylaxis of hemophilia A in patients at least 12 years old.</li><li>A final decision from the European Commission usually takes ~60 days.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454965\" data-linked=\"European advisory group backs Novo&#39;s Esperoct for hemophilia A\" data-tweet=\"$NVO - European advisory group backs Novo&#39;s Esperoct for hemophilia A https://seekingalpha.com/news/3454965-european-advisory-group-backs-novos-esperoct-for-hemophilia?source=tweet\" data-url=\"https://seekingalpha.com/news/3454965-european-advisory-group-backs-novos-esperoct-for-hemophilia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454963\" data-ts=\"1556291641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HELE\" target=\"_blank\">HELE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454963-helen-of-troy-soars-after-strong-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Helen of Troy soars after strong guidance</a></h4><ul> <li>FY20 revenue of $1.58B to $1.611B is <a href=\"https://seekingalpha.com/pr/17489502-helen-troy-limited-reports-fourth-quarter-fiscal-2019-results\" target=\"_blank\">anticipated</a> vs. $1.56 consensus and EPS of $8.25 to $8.50 vs. $8.09 consensus.</li><li>Helen of Troy (<a href='https://seekingalpha.com/symbol/HELE' title='Helen of Troy Limited'>HELE</a> <font color='green'>+20%</font>) expects adjusted EPS growth for FY20 to be concentrated in the second half of the year due to the strong performance comparison and specific events in the first half.</li> <li>HELE trades at its highest level of 2019.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3454963\" data-linked=\"Helen of Troy soars after strong guidance\" data-tweet=\"$HELE - Helen of Troy soars after strong guidance https://seekingalpha.com/news/3454963-helen-of-troy-soars-after-strong-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3454963-helen-of-troy-soars-after-strong-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454959\" data-ts=\"1556291237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOVA\" target=\"_blank\">DOVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454959-european-advisory-group-backs-dova-pharmas-doptelet-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European advisory group backs Dova Pharma&#39;s Doptelet; shares up 4%</a></h4><ul><li>The European Medicines Agency's advisory group CHMP has adopted a <a href=\"https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-doptelet_en.pdf\" target=\"_blank\">positive opinion</a> recommending approval for Dova Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals, Inc.'>DOVA</a> <font color=\"green\">+3.9%</font>) Doptelet (avatrombopag) for the treatment of severe thrombocytopenia in adults with chronic liver disease who are scheduled to undergo an invasive procedure.</li><li>A final decision from the European Commission usually takes ~60 days.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454959\" data-linked=\"European advisory group backs Dova Pharma&#39;s Doptelet; shares up 4%\" data-tweet=\"$DOVA - European advisory group backs Dova Pharma&#39;s Doptelet; shares up 4% https://seekingalpha.com/news/3454959-european-advisory-group-backs-dova-pharmas-doptelet-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3454959-european-advisory-group-backs-dova-pharmas-doptelet-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454952\" data-ts=\"1556290978\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BGG\" target=\"_blank\">BGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454952-briggs-stratton-stumbles-13-on-q3-earnings-miss-lowers-fy19-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Briggs &amp; Stratton stumbles 13% on Q3 earnings miss; lowers FY19 guidance</a></h4><ul><li>Briggs &amp; Stratton (<a href='https://seekingalpha.com/symbol/BGG' title='Briggs & Stratton Corporation'>BGG</a> <font color=\"red\">-13.2%</font>) reported Q3 net sales decreased of 4% Y/Y to $580.2M, driven by continued weather-related market softness in Australia and Europe, and impact to U.S. sales from the Sears bankruptcy.</li><li>Engines segment: Sales $336.24M (-12.5% Y/Y); adj. gross margin of 21.8% <font color=\"red\">down by 360 bps</font>, due to unfavorable sales mix, reduction in manufacturing volume as planned and inefficiencies; and adj. segment income as % of sales 8.3% <font color=\"red\">down by 490 bps</font>.</li><li>Product segment: Sales $271.21M (+10.6% Y/Y); adj. gross margin of 10.2% <font color=\"red\">down by 360 bps</font>; and adj. segment income as % of sales -0.4% <font color=\"red\">down 190 bps</font>.</li><li>Q3 Gross margin <font color=\"red\">declined by 485 bps</font> to 16.7%; adj. gross margin <font color=\"red\">declined by 450 bps</font> to 17.4%; and operating margin <font color=\"red\">declined by 544 bps</font> to 3%.</li><li>Net Cash used in operating activities YTD was $104.89M, compared to $19.02M.</li><li><strong>FY19 Guidance, lowered:</strong> Sales $1.86B to $1.91B (prior $1.90B to $1.96B); EPS $0.45 to $0.55 (prior $1.10 to $1.30); operating margin 2.6% to 2.8% (prior 4.5% to 4.8%); tax rate in range of 10% to 12%; Capex ~$65M.</li><li><strong>FY20 Guidance:</strong> Net sales $1.98B to $2.03B; and EPS $1.20 to $1.40.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454627-briggs-and-stratton-misses-0_31-beats-revenue\" target=\"_blank\">Briggs &amp; Stratton misses by $0.31, beats on revenue</a> (April 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454566-briggs-and-stratton-declares-0_14-dividend\" target=\"_blank\">Briggs &amp; Stratton declares $0.14 dividend</a> (April 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454952\" data-linked=\"Briggs &amp; Stratton stumbles 13% on Q3 earnings miss; lowers FY19 guidance\" data-tweet=\"$BGG - Briggs &amp; Stratton stumbles 13% on Q3 earnings miss; lowers FY19 guidance https://seekingalpha.com/news/3454952-briggs-stratton-stumbles-13-on-q3-earnings-miss-lowers-fy19-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3454952-briggs-stratton-stumbles-13-on-q3-earnings-miss-lowers-fy19-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454956\" data-ts=\"1556290911\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454956-aratana-therapeutics-and-repligen-among-healthcare-gainers-biotelemetry-and-immunic-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aratana Therapeutics and Repligen among healthcare gainers; BioTelemetry and Immunic among losers</a></h4><ul><li><b>Gainers: </b>Regional Health Properties (NYSEMKT:<a href='https://seekingalpha.com/symbol/RHE' title='Regional Health Properties, Inc.'>RHE</a>) <font color=\"green\">+57%</font>. Aratana Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics, Inc.'>PETX</a>) <font color=\"green\">+37%</font>. India Globalization Capital (NYSEMKT:<a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc.'>IGC</a>) <font color=\"green\">+26%</font>. Repligen (NASDAQ:<a href='https://seekingalpha.com/symbol/RGEN' title='Repligen Corporation'>RGEN</a>) <font color=\"green\">+18%</font>. Miragen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGEN' title='Miragen Therapeutics, Inc.'>MGEN</a>) <font color=\"green\">+12%</font>.</li><li><b>Losers: </b>Ra Medical Systems (NYSE:<a href='https://seekingalpha.com/symbol/RMED' title='Ra Medical Systems, Inc.'>RMED</a>) <font color=\"red\">-13%</font>. Fulgent Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/FLGT' title='Fulgent Genetics, Inc.'>FLGT</a>) <font color=\"red\">-11%</font>. Diffusion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DFFN' title='Diffusion Pharmaceuticals Inc.'>DFFN</a>) <font color=\"red\">-7%</font>. BioTelemetry (NASDAQ:<a href='https://seekingalpha.com/symbol/BEAT' title='BioTelemetry, Inc.'>BEAT</a>) <font color=\"red\">-6%</font>. Immunic (NASDAQ:<a href='https://seekingalpha.com/symbol/IMUX' title='Immunic, Inc.'>IMUX</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454956\" data-linked=\"Aratana Therapeutics and Repligen among healthcare gainers; BioTelemetry and Immunic among losers\" data-tweet=\"$RHE $PETX $IGC - Aratana Therapeutics and Repligen among healthcare gainers; BioTelemetry and Immunic among losers https://seekingalpha.com/news/3454956-aratana-therapeutics-and-repligen-among-healthcare-gainers-biotelemetry-and-immunic-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3454956-aratana-therapeutics-and-repligen-among-healthcare-gainers-biotelemetry-and-immunic-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454953\" data-ts=\"1556290829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454953-avengers-lift-u-s-box-office-for-weeks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avengers could lift U.S. box office for weeks</a></h4><ul> <li>Theater stocks are gaining as more buzz generates over <em>Avengers:Endgame</em>. While a gigantic opening weekend was already largely anticipated, the Marvel film's \"A\" Cinemascore and 96% rating on Rotten Tomatoes are both indications that the superhero mashup will have some legs for a while.</li> <li>Marcus Corporation (NYSE:<a href='https://seekingalpha.com/symbol/MCS' title='The Marcus Corporation'>MCS</a>) is <font color=\"green\">up 3.1%</font>, while AMC Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc.'>AMC</a>) and Cinemark (NYSE:<a href='https://seekingalpha.com/symbol/CNK' title='Cinemark Holdings, Inc.'>CNK</a>) are both <font color=\"green\">1.4% higher</font>.</li><li>Avengers arrives with the U.S box office down 17% YTD through April 24.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3454820-amc-points-blowout-numbers-avengers\" target=\"_blank\">AMC points to blowout numbers for Avengers</a> (April 26)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454950-avengers-finale-opens-record-assault-60m-thursday\" target=\"_blank\">'Avengers' finale opens record assault with $60M Thursday</a> (April 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3454953\" data-linked=\"Avengers could lift U.S. box office for weeks\" data-tweet=\"$MCS $AMC $CNK - Avengers could lift U.S. box office for weeks https://seekingalpha.com/news/3454953-avengers-lift-u-s-box-office-for-weeks?source=tweet\" data-url=\"https://seekingalpha.com/news/3454953-avengers-lift-u-s-box-office-for-weeks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454943\" data-ts=\"1556289149\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEM\" target=\"_blank\">AEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454943-agnico-eagle-beats-on-top-and-bottom-lines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agnico Eagle beats on top and bottom lines</a></h4><ul><li>Agnico Eagle Mines (<a href='https://seekingalpha.com/symbol/AEM' title='Agnico Eagle Mines Limited'>AEM</a> <font color='green'>+3.2%</font>) reports a decline in <a href=\"https://seekingalpha.com/news/3454623-agnico-eagle-beats-0_08-beats-revenue\" target=\"_blank\">Q1 earnings</a> that nevertheless easily beat expectations as well as an 8% Y/Y decline in revenue that also topped estimates.</li><li>AEM says Q1 gold production edged 2% higher Y/Y to 398.2K oz., including pre-commercial production of 17.6K oz. at its Meliadine project, at an all-in sustaining cost of $836/oz. vs. year-ago AISC of $889/oz.</li><li>Without Meliadine, production and sales fell from the year-ago  period primarily due to expected reduced throughput levels at the Meadowbank mine, which transitions to the Amaruq satellite deposit.</li><li>AEM maintains full-year production guidance of 1.75M oz. of gold, including a combined 100K oz. of pre-commercial output from the Meliadine and Amaruq projects, at all-in sustaining costs of $875-$925/oz.; the company expects 55% of forecast 2019 gold production will occur in H2.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454943\" data-linked=\"Agnico Eagle beats on top and bottom lines\" data-tweet=\"$AEM - Agnico Eagle beats on top and bottom lines https://seekingalpha.com/news/3454943-agnico-eagle-beats-on-top-and-bottom-lines?source=tweet\" data-url=\"https://seekingalpha.com/news/3454943-agnico-eagle-beats-on-top-and-bottom-lines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454942\" data-ts=\"1556289027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDAIF\" target=\"_blank\">DDAIF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454942-daimler-battles-through-challenges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Daimler battles through challenges</a></h4><ul> <li>Daimler (<a href='https://seekingalpha.com/symbol/DDAIF' title='Daimler AG'>OTCPK:DDAIF</a>) trades higher after maintaining its revenue and profit outlook for the full year, despite a difficult <a href=\"https://www.daimler.com/investors/reports-news/interim-reports/2019/q1/\" target=\"_blank\">Q1</a> that saw auto profits fall 37% Y/Y. The truck business was also impacted negatively by higher raw material costs and supply chain issues.</li> <li>\"We had a comparatively weak start to the year and face numerous challenges along the entire value chain in all our automotive divisions. This had a negative impact on unit sales and earnings,\" summed up Daimler CFO Bodo Uebber on the quarter.</li> <li>Daimler is <font color=\"green\">up 1.09%</font> in Frankfurt trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3454942\" data-linked=\"Daimler battles through challenges\" data-tweet=\"$DDAIF - Daimler battles through challenges https://seekingalpha.com/news/3454942-daimler-battles-through-challenges?source=tweet\" data-url=\"https://seekingalpha.com/news/3454942-daimler-battles-through-challenges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454940\" data-ts=\"1556288649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTLA\" target=\"_blank\">PTLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454940-portola-pharma-up-2-on-conditional-ok-in-europe-for-ondexxya\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Portola Pharma up 2% on conditional OK in Europe for Ondexxya</a></h4><ul><li>Portola Pharmaceuticals (<a href='https://seekingalpha.com/symbol/PTLA' title='Portola Pharmaceuticals, Inc.'>PTLA</a> <font color=\"green\">+1.7%</font>) perks up on light volume in early trade in response to the (expected) conditional authorization of Ondexxya (andexanet alfa) as a reversal agent for anticoagulants apixaban or rivaroxaban in Europe.</li><li>In February, the advisory group CHMP adopted a <a href=\"https://seekingalpha.com/news/3439046-european-advisory-group-backs-portolas-ondexxya-shares-7-percent-premarket\" target=\"_blank\">positive opinion</a> backing approval.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454940\" data-linked=\"Portola Pharma up 2% on conditional OK in Europe for Ondexxya\" data-tweet=\"$PTLA - Portola Pharma up 2% on conditional OK in Europe for Ondexxya https://seekingalpha.com/news/3454940-portola-pharma-up-2-on-conditional-ok-in-europe-for-ondexxya?source=tweet\" data-url=\"https://seekingalpha.com/news/3454940-portola-pharma-up-2-on-conditional-ok-in-europe-for-ondexxya\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454939\" data-ts=\"1556288518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPSC\" target=\"_blank\">SPSC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454939-sps-commerceplus-8-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SPS Commerce +8% post Q1 results</a></h4><ul><li>SPS Commerce (<a href='https://seekingalpha.com/symbol/SPSC' title='SPS Commerce, Inc.'>SPSC</a> <font color=\"green\">+8%</font>) reports <a href=\"https://seekingalpha.com/pr/17488977-sps-commerce-reports-first-quarter-2019-financial-results\" target=\"_blank\">Q1</a> revenue growth of 13.3% Y/Y to $66.93M.</li><li>Overall Q1 margin: Gross <font color=\"green\">increased 161 bps</font> to 68.2%; operating <font color=\"green\">increased 378 bps</font> to 11.1% &amp; Adj. EBITDA <font color=\"green\">increased 622 bps</font> to 24.7%.</li><li><b>Q2 2019 Guidance:</b> Revenue of $67.7-68.2M; EPS $0.33-0.35 with fully diluted weighted average shares outstanding of ~18M; Adj. EPS $0.51-0.53; Adj. EBITDA of $15.8-16.3M; SBC ~$3.3M; depreciation ~$2.8M and amortization ~$1.3M.</li><li><b>2019 Guidance:</b> Revenue of $275-276.5M; EPS $1.39-1.45 with fully diluted weighted average shares outstanding of ~18M; Adj. EPS $2.16-2.22; Adj. EBITDA of $65-66.5M; SBC ~$15.5M; depreciation ~$11.3M and amortization ~$5.2M</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454512-sps-commerce-beats-0_09-beats-revenue\" target=\"_blank\">SPS Commerce beats by $0.09, beats on revenue</a> (Apr. 25 2019).</li></ul><div class=\"tiny-share-widget\" data-id=\"3454939\" data-linked=\"SPS Commerce +8% post Q1 results\" data-tweet=\"$SPSC - SPS Commerce +8% post Q1 results https://seekingalpha.com/news/3454939-sps-commerceplus-8-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3454939-sps-commerceplus-8-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454937\" data-ts=\"1556287878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CL\" target=\"_blank\">CL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454937-colgate-palmolive-rallies-after-earnings-topper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Colgate-Palmolive rallies after earnings topper</a></h4><ul> <li>Colgate-Palmolive (<a href='https://seekingalpha.com/symbol/CL' title='Colgate-Palmolive Company'>CL</a> <font color='green'>+2.5%</font>) reports global unit volume was up 1.0% in <a href=\"https://seekingalpha.com/pr/17489506-colgate-announces-1st-quarter-2019-results\" target=\"_blank\">Q1</a> and pricing increase 2.0%.</li> <li>Organic sales were up 3% during the quarter. For the full year, Colgate-Palmolive anticipate organic sales growth of between 2% and 4%.</li> <li>Gross margin came in at 58.9% of sales vs. 60.2% a year ago and 59.5% consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454767-colgate-palmolive-beats-0_01-beats-revenue\" target=\"_blank\">Colgate-Palmolive beats by $0.01, beats on revenue</a> (April 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3454937\" data-linked=\"Colgate-Palmolive rallies after earnings topper\" data-tweet=\"$CL - Colgate-Palmolive rallies after earnings topper https://seekingalpha.com/news/3454937-colgate-palmolive-rallies-after-earnings-topper?source=tweet\" data-url=\"https://seekingalpha.com/news/3454937-colgate-palmolive-rallies-after-earnings-topper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454931\" data-ts=\"1556287876\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAVB\" target=\"_blank\">NAVB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454931-navidea-down-7-ahead-of-new-tilmanocept-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navidea down 7% ahead of new Tilmanocept study</a></h4><ul><li>Navidea Biopharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/NAVB' title='Navidea Biopharmaceuticals, Inc.'>NAVB</a>) is down <font color=\"red\">7%</font> on below-average volume in early trade following its <a href=\"https://seekingalpha.com/pr/17489588-navidea-biopharmaceuticals-announces-comparative-study-evaluate-potential-utility-tilmanocept\" target=\"_blank\">announcement </a>of a Tilmanocept study in tuberculosis &#40;TB&#41;.</li><li>The company says the comparative study will explore using 68Ga-Tilmanocept, a molecular probe, as an aid in managing TB patients while adding to the understanding of <a href=\"https://www.nejm.org/doi/full/10.1056/NEJMcibr0902539\" target=\"_blank\">TB granulomas</a> (cellular aggregates that characterize the infection).</li></ul><div class=\"tiny-share-widget\" data-id=\"3454931\" data-linked=\"Navidea down 7% ahead of new Tilmanocept study\" data-tweet=\"$NAVB - Navidea down 7% ahead of new Tilmanocept study https://seekingalpha.com/news/3454931-navidea-down-7-ahead-of-new-tilmanocept-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3454931-navidea-down-7-ahead-of-new-tilmanocept-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454926\" data-ts=\"1556287434\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USO\" target=\"_blank\">USO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454926-trump-tells-opec-to-bring-prices-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trump tells OPEC to bring prices down</a></h4><ul><li>Speaking to reporters, the president says he's been on the horn with OPEC, and told the cartel he wants lower prices for crude.</li><li>Black gold was already lower on the session, and has dipped a few more cents since the headline crossed - now <font color=\"red\">off 2%</font> to $63.90 per barrel. <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a> <font color=\"red\">-2%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/UHN' title='The United States Diesel-Heating Oil ETF, LP'>UHN</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3454926\" data-linked=\"Trump tells OPEC to bring prices down\" data-tweet=\"$USO $OIL $UWT - Trump tells OPEC to bring prices down https://seekingalpha.com/news/3454926-trump-tells-opec-to-bring-prices-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3454926-trump-tells-opec-to-bring-prices-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>119&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454924\" data-ts=\"1556287100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454924-sell-side-shakes-off-intel-print-looks-to-h2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-side shakes off Intel print, looks to H2</a></h4><ul><li>SunTrust raises its Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color=\"red\">-9.4%</font>) target from $53 to $56 and maintains a Hold rating after the earnings print that lowered the FY19 outlook.</li><li>The firm notes that Q2 guidance was far worse than expected on DCG and CCG trends, but the revised FY19 guide is only modestly lower and suggests an H2 improvement.</li><li>SunTrust thinks the DCG result is problematic for Nvidia (<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color=\"red\">-6.9%</font>), which gets 30% of its revenue from the data center.</li><li>Credit Suisse maintains an Outperform rating and $58 target saying that while Q1 and Q2 were worse than expected, but the thesis is still supported as data will drive accelerating compute TAM for all players with Intel remaining well positioned.</li><li>Concerns on 10nm yield/costs and positioning compared to AMD (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color=\"red\">-1.6%</font>) will continue to weigh on INTC's multiple until H2 estimates are met or exceeded, says the firm.</li><li>Jefferies chimes in that its field checks indicate AMD share gains will ramp in Q3 and sees Intel's issues as largely company-specific rather than an industry problem.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454577-intel-minus-6-percent-cut-2019-guidance\" target=\"_blank\">Intel -6% on cut 2019 guidance</a> (April 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454665-intel-updates-10nm-progress-earnings-call\" target=\"_blank\">Intel updates 10nm progress on earnings call</a> (April 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454924\" data-linked=\"Sell-side shakes off Intel print, looks to H2\" data-tweet=\"$INTC $INTC $NVDA - Sell-side shakes off Intel print, looks to H2 https://seekingalpha.com/news/3454924-sell-side-shakes-off-intel-print-looks-to-h2?source=tweet\" data-url=\"https://seekingalpha.com/news/3454924-sell-side-shakes-off-intel-print-looks-to-h2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454921\" data-ts=\"1556286600\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTNP\" target=\"_blank\">TTNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454921-titan-pharma-inks-8_6m-stock-sales-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Titan Pharma inks $8.6M stock sales deal</a></h4><ul><li>Titan Pharmaceuticals (<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a> <font color=\"red\">-1.6%</font>) has entered into an <a href=\"https://www.sec.gov/Archives/edgar/data/910267/000114420419021363/tv519685_424b5.htm\" target=\"_blank\">agreement</a> with Alliance Global Partners for the at-the-market sale of up to $8.6M of its common stock. Alliance will earn a 3% commission for its efforts.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454921\" data-linked=\"Titan Pharma inks $8.6M stock sales deal\" data-tweet=\"$TTNP - Titan Pharma inks $8.6M stock sales deal https://seekingalpha.com/news/3454921-titan-pharma-inks-8_6m-stock-sales-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3454921-titan-pharma-inks-8_6m-stock-sales-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454920\" data-ts=\"1556286340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454920-american-airlines-updates-on-max-impact\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Airlines updates on Max impact</a></h4><ul> <li>American Airlines Group (NASDAQ:<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group Inc.'>AAL</a>) is <font color=\"red\">down 1.51%</font> after the airline company lowers guidance due in part to the Boeing Max grounding and higher fuel costs.</li> <li>\"Although these aircraft represent a small portion of the company\u2019s total fleet, its financial impact is disproportionate as most of the revenue from the cancellations is lost while the vast majority of the costs remain in place,' noted CFO Derek Kerr on the Max situation.</li> <li>The company expects FY19 EPS of $4.00 to $6.00 vs. $5.50 to $7.00 prior and $5.65 consensus. Unit revenue is expected to rise 1% to 3% for the full year in an acceleration from the 0.5% pace in Q1.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454810-american-airlines-beats-0_02-misses-revenue\" target=\"_blank\">American Airlines beats by $0.02, misses on revenue</a> (April 26)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3454920\" data-linked=\"American Airlines updates on Max impact\" data-tweet=\"$AAL - American Airlines updates on Max impact https://seekingalpha.com/news/3454920-american-airlines-updates-on-max-impact?source=tweet\" data-url=\"https://seekingalpha.com/news/3454920-american-airlines-updates-on-max-impact\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454917\" data-ts=\"1556286091\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EOLS\" target=\"_blank\">EOLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454917-european-advisory-group-backs-evolus-nuceiva-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European advisory group backs Evolus&#39; Nuceiva; shares up 2%</a></h4><ul><li>The European Medicines Agency's advisory group CHMP has issued a <a href=\"https://seekingalpha.com/pr/17489742-evolus-receives-positive-chmp-opinion-nuceiva-european-union\" target=\"_blank\">positive opinion</a> recommending approval for Evolus' (<a href='https://seekingalpha.com/symbol/EOLS' title='Evolus, Inc.'>EOLS</a> <font color=\"green\">+2.1%</font>) Nuceiva (prabotulinumtoxinA-xvfs) for the temporary improvement of moderate-to-severe frown lines in adults below the age of 65.</li><li>A final decision from the European Commission usually takes ~60 days.</li><li>The product, branded as Jeuveau in the U.S., was <a href=\"https://seekingalpha.com/news/3428853-fda-oks-evolus-jeuveau-frown-lines\" target=\"_blank\">approved </a>by the FDA in early February.</li><li>Related ticker: Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color=\"red\">-0.1%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454917\" data-linked=\"European advisory group backs Evolus&#39; Nuceiva; shares up 2%\" data-tweet=\"$EOLS $AGN - European advisory group backs Evolus&#39; Nuceiva; shares up 2% https://seekingalpha.com/news/3454917-european-advisory-group-backs-evolus-nuceiva-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3454917-european-advisory-group-backs-evolus-nuceiva-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454914\" data-ts=\"1556285825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNSL\" target=\"_blank\">CNSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454914-consolidatedminus-5_3-analysts-process-eliminated-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consolidated -5.3% as analysts process eliminated dividend</a></h4><ul>   <li>After a <font color=\"red\">34% plunge</font> yesterday on <a href=\"https://seekingalpha.com/news/3454260-consoldated-comms-minus-24-percent-drops-dividend-reduce-leverage\" target=\"_blank\">eliminating its dividend</a>, Consolidated Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/CNSL' title='Consolidated Communications Holdings, Inc.'>CNSL</a>) was <font color=\"green\">up 3.8%</font> in premarket action just before the opening bell, and has come out <font color=\"red\">down 5.3%</font> after a pair of sell-side moves in opposite directions.</li>    <li>Wells Fargo is the bull here, upgrading to Outperform with a price target of $8. That target implies 37% upside from yesterday's close.</li>    <li>On the other side of the trade is Guggenheim, downgrading the shares to Sell on further downside from the dividend cut and deteriorating fundamentals. The firm has a $4 price target, implying 32% downside from yesterday's close.</li>    <li>Taking a more middle-of-the-road stance is Raymond James, cutting to Market Perform.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3454914\" data-linked=\"Consolidated -5.3% as analysts process eliminated dividend\" data-tweet=\"$CNSL - Consolidated -5.3% as analysts process eliminated dividend https://seekingalpha.com/news/3454914-consolidatedminus-5_3-analysts-process-eliminated-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3454914-consolidatedminus-5_3-analysts-process-eliminated-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454912\" data-ts=\"1556285586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EHTH\" target=\"_blank\">EHTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454912-sell-siders-rush-to-upgrade-ehealth-after-bullish-q1-despite-cash-flow-question\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-siders rush to upgrade eHealth after bullish Q1 despite cash flow question</a></h4><ul><li>Analysts at sell-side shops are waving their pom-poms after eHealth (<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a> <font color=\"green\">+16.2%</font>) posted better-than-expected <a href=\"https://seekingalpha.com/news/3454868-ehealth-13-percent-premarket-q1-beat-guidance-raise\" target=\"_blank\">Q1 results</a> after the close yesterday.</li><li>RBC's Frank Morgan (Outperform) has raised his price target to $89 (43% upside) from $83 citing the guidance raise on revenue and earnings.</li><li>Jefferies' David Styblo (NYSEARCA:<a href='https://seekingalpha.com/symbol/HOLD' title='AdvisorShares Sage Core Reserves ETF'>HOLD</a>) has boosted his target to $71 from $59 citing strong Medicare momentum and membership growth.</li><li>Cantor's Steven Halper (Overweight/$73) offers a more sober view, citing encouraging enrollment growth but countering that \"uncertainty exists.\"</li><li>Of note in the company's press release (unless it was worded incorrectly) was its cash flow ops guidance, forecasting a higher level of consumption for the year ($20M - 25M from $17M - 20M) despite generating $12.7M in Q1 and increasing its earnings guidance and revenue growth.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454912\" data-linked=\"Sell-siders rush to upgrade eHealth after bullish Q1 despite cash flow question\" data-tweet=\"$EHTH $HOLD - Sell-siders rush to upgrade eHealth after bullish Q1 despite cash flow question https://seekingalpha.com/news/3454912-sell-siders-rush-to-upgrade-ehealth-after-bullish-q1-despite-cash-flow-question?source=tweet\" data-url=\"https://seekingalpha.com/news/3454912-sell-siders-rush-to-upgrade-ehealth-after-bullish-q1-despite-cash-flow-question\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454909\" data-ts=\"1556285236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZAYO\" target=\"_blank\">ZAYO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454909-zayoplus-3-after-canceling-citi-conference\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zayo +3% after canceling Citi conference</a></h4><ul>   <li>Zayo Group (NYSE:<a href='https://seekingalpha.com/symbol/ZAYO' title='Zayo Group Holdings, Inc.'>ZAYO</a>) is <font color=\"green\">up 3%</font> premarket after canceling from the Citi Data Points Conference on May 10.</li>    <li>Conference schedules are driving a bit of the action around Zayo as reports continue to buzz about a potential or likely buyout by private equity. Yesterday, the stock was down after Zayo set some meetings at the NAREIT conference, Wells Fargo said in a note that suggested the scheduling wasn't necessarily negative for strategic talks.</li>    <li>Citi's Michael Rollins says the conference created a schedule conflict with the company reporting earnings after the close the day before.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3454909\" data-linked=\"Zayo +3% after canceling Citi conference\" data-tweet=\"$ZAYO - Zayo +3% after canceling Citi conference https://seekingalpha.com/news/3454909-zayoplus-3-after-canceling-citi-conference?source=tweet\" data-url=\"https://seekingalpha.com/news/3454909-zayoplus-3-after-canceling-citi-conference\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454907\" data-ts=\"1556285078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TREE\" target=\"_blank\">TREE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454907-lendingtreeplus-5_8-after-forecast-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LendingTree +5.8% after forecast boost</a></h4><ul><li>LendingTree (NASDAQ:<a href='https://seekingalpha.com/symbol/TREE' title='LendingTree, Inc.'>TREE</a>) <font color=\"green\">jumps 5.8%</font> in premarket trading after boosting its <a href=\"https://seekingalpha.com/pr/17489563-lendingtree-reports-record-1q-2019-results\" target=\"_blank\">2019 guidance</a> for revenue, variable marketing margin, and adjusted EBITDA.</li><li>Now sees 2019 revenue of $1.06B-$1.09B, up from prior view of $1.01B-$1.05B; consensus estimate of $1.03B.</li><li>Boosts 2019 adjusted EBITDA forecast to $210M-$220M from prior range of $205M-$215M.</li><li>Sees year variable marketing margin of $400M-$415M vs. prior range of $385M-$400M.</li><li>Q1 adjusted EPS of $1.10 compares with $1.10 in the year-ago quarter and $1.22 in Q4 2018.</li><li>Q1 total revenue of $262.4M beats the average analyst estimate of $239.7M and rises 45% Y/Y, up 29% Q/Q.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454783-lendingtree-misses-0_12-beats-revenue\" target=\"_blank\">LendingTree misses by $0.12, beats on revenue</a> (April 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454907\" data-linked=\"LendingTree +5.8% after forecast boost\" data-tweet=\"$TREE - LendingTree +5.8% after forecast boost https://seekingalpha.com/news/3454907-lendingtreeplus-5_8-after-forecast-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3454907-lendingtreeplus-5_8-after-forecast-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454903\" data-ts=\"1556284726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454903-earnings-movers-dominate-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Earnings movers dominate premarket gainers</a></h4><ul><li>Aratana Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics, Inc.'>PETX</a>) <font color=\"green\">+37%</font> on Elanco <a href=\"https://seekingalpha.com/news/3454775-aratana-32-percent-premarket-elanco-takeover\" target=\"_blank\">takeover</a>.</li><li>Regional Health Properties (NYSEMKT:<a href='https://seekingalpha.com/symbol/RHE' title='Regional Health Properties, Inc.'>RHE</a>) <font color=\"green\">+20%</font>.</li><li>Reebonz Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/RBZ' title='Reebonz Holding Limited'>RBZ</a>) <font color=\"green\">+17%</font>.</li><li>Highpower (NASDAQ:<a href='https://seekingalpha.com/symbol/HPJ' title='Highpower International, Inc.'>HPJ</a>) <font color=\"green\">+14%</font> on <a href=\"https://seekingalpha.com/pr/17489685-highpower-international-receives-additional-commitment-consortium\" target=\"_blank\">receiving</a> additional commitment from consortium.</li><li>Grubhub (NYSE:<a href='https://seekingalpha.com/symbol/GRUB' title='GrubHub, Inc.'>GRUB</a>) <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/news/3454456-grubhub-beats-0_05-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Pareteum (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/news/3454849-pareteum-plus-6-percent-new-bull\" target=\"_blank\">new bull</a>.</li><li>Ford Motor (NYSE:<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/news/3454510-ford-motor-beats-0_17-misses-automotive-revenue\" target=\"_blank\">Q1 earnings</a> and <a href=\"https://seekingalpha.com/news/3454869-ford-discloses-doj-probe-emission-certification\" target=\"_blank\">disclosing</a> DOJ probe on emission certification.</li><li>The Medicines (NASDAQ:<a href='https://seekingalpha.com/symbol/MDCO' title='The Medicines Company'>MDCO</a>) <font color=\"green\">+6%</font>.</li><li>Mattel (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/news/3454490-mattel-beats-0_11-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Shutterfly (NASDAQ:<a href='https://seekingalpha.com/symbol/SFLY' title='Shutterfly, Inc.'>SFLY</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/news/3454479-shutterfly-beats-0_10-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>The Goodyear Tire &amp; Rubber (NASDAQ:<a href='https://seekingalpha.com/symbol/GT' title='The Goodyear Tire & Rubber Company'>GT</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3454853-goodyear-tire-and-rubber-beats-0_07-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454903\" data-linked=\"Earnings movers dominate premarket gainers\" data-tweet=\"$PETX $RHE $RBZ - Earnings movers dominate premarket gainers https://seekingalpha.com/news/3454903-earnings-movers-dominate-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3454903-earnings-movers-dominate-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454897\" data-ts=\"1556284290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOXC\" target=\"_blank\">MOXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454897-intc-and-wdc-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">INTC and WDC among premarket losers</a></h4><ul><li>Moxian (NASDAQ:<a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a>) <font color=\"red\">-10%</font>.</li><li>Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) <font color=\"red\">-8%</font> on <a href=\"https://seekingalpha.com/news/3454427-intel-beats-0_02-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>SandRidge Permian (NYSE:<a href='https://seekingalpha.com/symbol/PER' title='SandRidge Permian Trust'>PER</a>) <font color=\"red\">-7%</font>.</li><li>Bitauto (NYSE:<a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a>) <font color=\"red\">-6%</font>.</li><li>Moleculin Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a>) <font color=\"red\">-7%</font>.</li><li>Western Digital (NASDAQ:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) <font color=\"red\">-5%</font> on <a href=\"https://seekingalpha.com/news/3454817-western-digital-gets-two-notch-downgrade-wdc-minus-3-percent\" target=\"_blank\">analyst downgrade</a>.</li><li>Atossa Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics Inc.'>ATOS</a>) <font color=\"red\">-4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454897\" data-linked=\"INTC and WDC among premarket losers\" data-tweet=\"$MOXC $PER $BITA - INTC and WDC among premarket losers https://seekingalpha.com/news/3454897-intc-and-wdc-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3454897-intc-and-wdc-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454895\" data-ts=\"1556284235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGEN\" target=\"_blank\">MGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454895-miragen-up-19-premarket-in-encouraging-cobomarsen-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MiRagen up 19% premarket in encouraging cobomarsen data</a></h4><ul><li>Thinly traded nano cap miRagen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGEN' title='Miragen Therapeutics, Inc.'>MGEN</a>) perks up <font color=\"green\">19%</font> premarket, albeit on light volume, on the heels of new <a href=\"https://seekingalpha.com/pr/17489551-miragen-announces-new-clinical-data-cobomarsen-atll-patients-19th-annual-htlv-congress-lima\" target=\"_blank\">interim data</a> from a Phase 1 clinical trial evaluating cobomarsen in adult patients with T-cell leukemia/lymphoma &#40;ATLL&#41;. The results were presented at the International Congress HTLV in Lima, Peru.</li><li>Five participants with an aggressive subtype of ATLL have been treated with cobomarsen for up to 16 months. Four of the five remained stable up to the 16-month period and continue on study. Published data suggest that these patients usually die within 4 - 10 months of their diagnoses.</li><li>Cabomarsen has shown a favorable safety profile thus far.</li><li>The company is currently assessing the microRNA-155 inhibitor in three blood cancer indications: ATLL, diffuse large B-cell lymphoma and chronic lymphocytic leukemia.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454895\" data-linked=\"MiRagen up 19% premarket in encouraging cobomarsen data\" data-tweet=\"$MGEN - MiRagen up 19% premarket in encouraging cobomarsen data https://seekingalpha.com/news/3454895-miragen-up-19-premarket-in-encouraging-cobomarsen-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3454895-miragen-up-19-premarket-in-encouraging-cobomarsen-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454884\" data-ts=\"1556283687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PATK\" target=\"_blank\">PATK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454884-baml-drops-patrick-industries-two-notches\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML drops Patrick Industries two notches</a></h4><ul> <li>Bank of America Merrill Lynch lowers Patrick Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/PATK' title='Patrick Industries, Inc.'>PATK</a>) to an Underperform rating in a two-notch lowering from Buy after taking in the 76% YTD rally in share price.</li> <li>\"We believe the benefits of supplying industries outside of recreational vehicles will be insufficient in the near-term to offset the ongoing RV dealer inventory correction,\" warns the BAML analyst team</li> <li>\"We expect the inventory correction to persist at least into CY3Q19, challenging manufacturers and suppliers to the greatest extent. Risk of prolonged pressure exists if retail demand for RVs does not re-accelerate and/or dealers continue to operate on a more just-in-time basis with lower levels of inventory. Outside of RVs, we continue to view PATK\u2019s exposure to affordable housing through its Manufactured Home and Industrial segments favorably, given our positive view on overall housing trends and the entry-level/first-time buyer in particular.\"</li> <li>Shares of Patrick Industries are <font color=\"red\">down 1.44%</font> in premarket trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3454884\" data-linked=\"BAML drops Patrick Industries two notches\" data-tweet=\"$PATK - BAML drops Patrick Industries two notches https://seekingalpha.com/news/3454884-baml-drops-patrick-industries-two-notches?source=tweet\" data-url=\"https://seekingalpha.com/news/3454884-baml-drops-patrick-industries-two-notches\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454879\" data-ts=\"1556283204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACB\" target=\"_blank\">ACB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454879-bernstein-likes-gilead-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bernstein likes Gilead in premarket analyst action</a></h4><ul><li>Aurora Cannabis (NYSE:<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>) initiated with Buy rating and C$16.50 (35% upside) price target at Desjardins. Shares up <font color=\"green\">1% </font>premarket on the heels of its license deal with EnWave.</li><li>Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) initiated with Outperform rating and $82 (29% upside) at Bernstein. Shares up <font color=\"green\">1%</font> premarket.</li><li>Tocagen (NASDAQ:<a href='https://seekingalpha.com/symbol/TOCA' title='Tocagen Inc.'>TOCA</a>) initiated with Overweight rating and $28 price target at Cantor Fitzgerald.</li><li>Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) [ticker in Canada is \"WEED\"] initiated with Hold rating and C$74 (14% upside) price target at Desjardins.</li><li>The Medicines Company (NASDAQ:<a href='https://seekingalpha.com/symbol/MDCO' title='The Medicines Company'>MDCO</a>) upgraded to Buy with a $55 (85% upside) price target at Goldman Sachs on bullish prospects for inclisiran. Shares up <font color=\"green\">7% </font>premarket.</li><li>Fulgent Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/FLGT' title='Fulgent Genetics, Inc.'>FLGT</a>) downgraded to Neutral with an $8 (9% upside) price target at Credit Suisse.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454879\" data-linked=\"Bernstein likes Gilead in premarket analyst action\" data-tweet=\"$ACB $GILD $TOCA - Bernstein likes Gilead in premarket analyst action https://seekingalpha.com/news/3454879-bernstein-likes-gilead-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3454879-bernstein-likes-gilead-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454873\" data-ts=\"1556282769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454873-exxon-slides-earnings-revenues-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exxon slides as earnings, revenues disappoint</a></h4><ul><li>Exxon Mobil (NYSE:<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a>) <font color=\"red\">-2.4%</font> pre-market after missing Wall Street estimates for both <a href=\"https://seekingalpha.com/news/3454836-exxon-mobil-misses-0_13-misses-revenue\" target=\"_blank\">Q1 earnings</a> and revenues, which fell 7% Y/Y to $63.6B.</li><li>XOM says the change in Canadian crude differentials, as well as heavy scheduled maintenance, similar to Q4 2018, affected Q1 results.</li><li>Q1 production rose 2% Y/Y to 3.98M boe/day, with upstream liquids production increasing 5%, driven by Permian unconventional growth of nearly 140%.</li><li>In XOM's upstream business, crude prices strengthened  but remained weaker on average than in Q4 2018; North American differentials narrowed, largely due to imposed production curtailments in Canada and additional takeaway capacity in the Permian Basin.</li><li>In its downstream business, XOM says weak industry fuels margins from high gasoline inventory levels and narrowed North American crude differentials impacted results in the quarter, while chemicals margins remained challenged with continued supply length from recent industry capacity additions.</li><li>Q1 capex jumped 42% to $6.9B, reflecting investments in the Permian Basin.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454873\" data-linked=\"Exxon slides as earnings, revenues disappoint\" data-tweet=\"$XOM - Exxon slides as earnings, revenues disappoint https://seekingalpha.com/news/3454873-exxon-slides-earnings-revenues-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3454873-exxon-slides-earnings-revenues-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454870\" data-ts=\"1556282475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WETF\" target=\"_blank\">WETF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454870-wisdomtreeminus-1_8-q1-revenue-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WisdomTree -1.8% as Q1 revenue disappoints</a></h4><ul><li>WisdomTree Investments (NASDAQ:<a href='https://seekingalpha.com/symbol/WETF' title='WisdomTree Investments, Inc.'>WETF</a>)<font color=\"red\"> falls 1.8%</font> in premarket trading after<a href=\"https://seekingalpha.com/pr/17489550-wisdomtree-announces-first-quarter-2019-results\" target=\"_blank\"> Q1 adjusted EPS</a> of 5 cents matches the consensus estimate and revenue of $65.5M falls short by $1.3M.</li><li>Assets under management of $58.9B at March 31, 2019 increased 8% from Q4-end and 31% from March 31, 2018.</li><li>Q1 net inflows of $0.6B improved from $0.2B in Q4 and outflows of $2.2B in Q1 2018.</li><li>Q1 adjusted net income of $7.7M, or 5 cents per share, compares with $9.8M or 6 cents per share, in Q4 and $11.0M, or 8 cents per share, in Q1 2018.</li><li>Q1 total revenue of $65.5M compares with $67.2M in Q4 2018 and $58.5M in the year-ago quarter.</li><li>Q1 adjusted operating income margin fell to 19.9% from 21.9% in Q4 and 25.9% in Q1 2018.</li><li><a href=\"http://ir.wisdomtree.com/events/event-details/wisdomtree-q1-earnings-call-4\" target=\"_blank\">Conference call </a>at 9:00 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454780-wisdomtree-investments-eps-line-misses-revenue\" target=\"_blank\">WisdomTree Investments EPS in-line, misses on revenue</a> (April 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454870\" data-linked=\"WisdomTree -1.8% as Q1 revenue disappoints\" data-tweet=\"$WETF - WisdomTree -1.8% as Q1 revenue disappoints https://seekingalpha.com/news/3454870-wisdomtreeminus-1_8-q1-revenue-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3454870-wisdomtreeminus-1_8-q1-revenue-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454868\" data-ts=\"1556282088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EHTH\" target=\"_blank\">EHTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454868-ehealth-up-13-premarket-after-q1-beat-guidance-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EHealth up 13% premarket after Q1 beat, guidance raise</a></h4><ul><li>Health insurance exchange operator eHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a>) is up <font color=\"green\">13%</font> premarket on light volume following its <a href=\"https://seekingalpha.com/pr/17489038-ehealth-inc-announces-first-quarter-2019-results\" target=\"_blank\">Q1 results</a> released after the close yesterday. Highlights:</li><li>Revenue was up 60% to $68.8M, including a 78% jump in the Medicare segment to $30.8M.</li><li>Estimated membership was up 7% to 952,239.</li><li>Non-GAAP EBITDA was $8.6M compared to a loss of $1.2M a year ago.</li><li>Cash flow ops was up almost 19% to $12.7M.</li><li><strong>2019 guidance</strong>: Revenue: $315M - 335M from $290M - 310M; Medicare segment revenue: $281M - 297M from $256M - 272M; EPS: $0.60 - 0.79 (unch); non-GAAP EPS: $1.54 - 1.73 from $1.11 - 1.25; non-GAAP EBITDA: $55M - 60M from $45M - 50M; cash consumption by operations: $20M - 25M from $17M - 20M.</li><li>Cash consumption guidance is noteworthy considering the $12.7M generated in Q1, implying a negative cash flow ops of ($32.7M - 37.7M) during the last three quarters while revenue growth and earnings are projected to be positive for the year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454546-ehealth-beats-0_45-beats-revenue\" target=\"_blank\">eHealth beats by $0.45, beats on revenue</a> (April 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454868\" data-linked=\"EHealth up 13% premarket after Q1 beat, guidance raise\" data-tweet=\"$EHTH - EHealth up 13% premarket after Q1 beat, guidance raise https://seekingalpha.com/news/3454868-ehealth-up-13-premarket-after-q1-beat-guidance-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3454868-ehealth-up-13-premarket-after-q1-beat-guidance-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454862\" data-ts=\"1556281831\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GT\" target=\"_blank\">GT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454862-goodyear-tire-rubberplus-1-after-mixed-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goodyear Tire &amp; Rubber +1% after mixed Q1</a></h4><ul> <li>Goodyear Tire &amp; Rubber (NASDAQ:<a href='https://seekingalpha.com/symbol/GT' title='The Goodyear Tire & Rubber Company'>GT</a>) reports a 3% drop in tire unit volume for Q1. Original equipment volume was 7% lower during the quarter, while replacement tire shipments fell less than 1%.</li> <li>Segment operating income was $190M vs. $281M a year ago as higher raw material costs, lower volume, unfavorable foreign currency translation and weaker results from other tire-related businesses dragged on results.</li> <li>\"We gained momentum in the U.S. during the quarter, as our consumer and commercial replacement businesses both grew share, while increasing the value we capture in the marketplace,\" notes Goodyear CEO Richard Kramer.</li> <li>Shares of Goodyear Tire &amp; Rubber are <font color=\"green\">up 1.44%</font> premarket to $20.98 after showing some weakness the last few days in front of the report.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454853-goodyear-tire-and-rubber-beats-0_07-misses-revenue\" target=\"_blank\">Goodyear Tire &amp; Rubber beats by $0.07, misses on revenue</a> (April 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3454862\" data-linked=\"Goodyear Tire &amp; Rubber +1% after mixed Q1\" data-tweet=\"$GT - Goodyear Tire &amp; Rubber +1% after mixed Q1 https://seekingalpha.com/news/3454862-goodyear-tire-rubberplus-1-after-mixed-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3454862-goodyear-tire-rubberplus-1-after-mixed-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454853\" data-ts=\"1556281099\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GT\" target=\"_blank\">GT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454853-goodyear-tire-and-amp-rubber-beats-0_07-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goodyear Tire &amp;amp; Rubber beats by $0.07, misses on revenue</a></h4><ul><li>Goodyear Tire &amp; Rubber (NASDAQ:<a href='https://seekingalpha.com/symbol/GT' title='The Goodyear Tire & Rubber Company'>GT</a>): Q1 Non-GAAP EPS of $0.19 <span style=\"color:green\">beats by $0.07</span>; GAAP EPS of -$0.26.</li><li>Revenue of $3.6B (-6.0% Y/Y) <font color=\"red\">misses by $140M</font>.</li><li>Shares <font color=\"green\">+2.2%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17489667-goodyear-reports-first-quarter-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3454853\" data-linked=\"Goodyear Tire &amp;amp; Rubber beats by $0.07, misses on revenue\" data-tweet=\"$GT - Goodyear Tire &amp; Rubber beats by $0.07, misses on revenue https://seekingalpha.com/news/3454853-goodyear-tire-and-amp-rubber-beats-0_07-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3454853-goodyear-tire-and-amp-rubber-beats-0_07-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454849\" data-ts=\"1556280857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454849-pareteumplus-6-on-new-bull\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum +6% on new bull</a></h4><ul><li>Pareteum (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) gains 6.4% to $4.14 following the after the bell Oppenheimer initiation.</li><li>The firm starts TEUM at Outperform and a $7 price target.</li><li>TEUM is expected to report earnings on May 7. Consensus <a href=\"https://seekingalpha.com/symbol/TEUM/earnings\" target=\"_blank\">estimates</a> have revenue at $19.62M with a $0.04 loss per share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454849\" data-linked=\"Pareteum +6% on new bull\" data-tweet=\"$TEUM - Pareteum +6% on new bull https://seekingalpha.com/news/3454849-pareteumplus-6-on-new-bull?source=tweet\" data-url=\"https://seekingalpha.com/news/3454849-pareteumplus-6-on-new-bull\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454844\" data-ts=\"1556280334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADM\" target=\"_blank\">ADM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454844-archer-daniels-midlandminus-2-after-soggy-profits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Archer Daniels Midland -2% after soggy profits</a></h4><ul> <li>Archer Daniels Midland (NYSE:<a href='https://seekingalpha.com/symbol/ADM' title='Archer-Daniels-Midland Company'>ADM</a>) says <a href=\"https://seekingalpha.com/news/3454774-archer-daniels-midland-misses-0_16-misses-revenue\" target=\"_blank\">Q1</a> operating profit took a $60M hit from harsh weather in the Midwest, particularly flooding that disrupted rail traffic.</li> <li>Operating profit in the origination, carbohydrate and nutrition segments all came in below expectations. Q1 EPS arrived in below even the lowest estimate turned in by analysts for the quarter.</li> <li>As part of its earnings release, ADM discloses that it's creating an ethanol plant subsidiary and may consider a spinoff of the segment in the future.</li> <li>Shares of Archer Daniels Midland are <font color=\"red\">down 1.65%</font> in premarket trading to $41.08.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454774-archer-daniels-midland-misses-0_16-misses-revenue\" target=\"_blank\">Archer Daniels Midland misses by $0.16, misses on revenue</a> (April 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3454844\" data-linked=\"Archer Daniels Midland -2% after soggy profits\" data-tweet=\"$ADM - Archer Daniels Midland -2% after soggy profits https://seekingalpha.com/news/3454844-archer-daniels-midlandminus-2-after-soggy-profits?source=tweet\" data-url=\"https://seekingalpha.com/news/3454844-archer-daniels-midlandminus-2-after-soggy-profits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454843\" data-ts=\"1556280324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEA\" target=\"_blank\">LEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454843-lear-corporation-down-3-on-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lear Corporation down 3% on earnings miss</a></h4><ul><li>Lear Corporation (NYSE:<a href='https://seekingalpha.com/symbol/LEA' title='Lear Corporation'>LEA</a>) reports sales dropped 5% in <a href=\"https://seekingalpha.com/pr/17489476-lear-reports-first-quarter-2019-results\" target=\"_blank\">Q1</a>, excluding foreign exchange impact.</li><li>Segment sales: Seating: $3.91B (-9.6%); E-Systems: $1.25B (-11.2%).</li><li>North America net sales decreased 8.7% to $1.88B.</li><li>Europe and Africa net sales fell 11.1 to 2.17B.</li><li>Core operating margins declined 130 bps to 7.3%.</li><li>During the quarter, the company repurchased 804.27K shares for $118M.</li><li><strong>FY2019 Guidance</strong>: Net sales: $20.9B to $21.7B; Core operating earnings: $1.6B to $1.7B; Adjusted EBITDA: $2.12B to $2.22B; Interest Expense: ~$100M; Tax rate: 22% to 23%; Adjusted net income: $1.08B to $1.17B; Restructuring costs: ~$140M; Capital spending: ~$700M; Free cash flow: $850M to $950M.</li><li>LEA <font color=\"red\">-3.32%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454732-lear-misses-0_11-misses-revenue\" target=\"_blank\">Lear misses by $0.11, misses on revenue</a> (April 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454843\" data-linked=\"Lear Corporation down 3% on earnings miss\" data-tweet=\"$LEA - Lear Corporation down 3% on earnings miss https://seekingalpha.com/news/3454843-lear-corporation-down-3-on-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3454843-lear-corporation-down-3-on-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454841\" data-ts=\"1556280244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QRVO\" target=\"_blank\">QRVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454841-qorvo-fails-to-qualify-for-new-iphone-keybanc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qorvo fails to qualify for new iPhone - KeyBanc</a></h4><ul><li>KeyBanc cuts Qorvo (NASDAQ:<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc.'>QRVO</a>) from Overweight to Sector Weight.</li><li>Analyst John Vinh says QRVO \"has failed to be qualified in the new iPhone, despite having secured a design win.\" He cites supply chain checks and notes this puts estimates at risk.</li><li>The analyst doesn't think this was performance related, but rather due \"unsuccessful qualification of the part for production.\"</li><li>Vinh: \"QRVO will be unable to keep mobile revenues flat this year given its loss of market share.\"</li><li>QRVO is <font color=\"red\">down 2.5%</font> pre-market to $75.38.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454841\" data-linked=\"Qorvo fails to qualify for new iPhone - KeyBanc\" data-tweet=\"$QRVO - Qorvo fails to qualify for new iPhone - KeyBanc https://seekingalpha.com/news/3454841-qorvo-fails-to-qualify-for-new-iphone-keybanc?source=tweet\" data-url=\"https://seekingalpha.com/news/3454841-qorvo-fails-to-qualify-for-new-iphone-keybanc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454826\" data-ts=\"1556279493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454826-analysts-adjust-amazon-targets-after-earnings-smasher-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts adjust Amazon targets after earnings smasher; shares up 1%</a></h4><ul><li>Cowen raises its Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) target from $2,250 to $2,400 and maintains an Outperform rating, citing the \"game-changing\" shift to free one-day shipping for core Prime customers.</li><li>Morgan Stanley cuts its Amazon PT by $100 to $2,100.</li><li>Goldman raises its PT from $2,100 to $2,400 and maintains a Buy rating.</li><li>Update: RBC 's Mark Mahaney calls the one-day shipping shift \"big news\" for believers in shipping elasticity and calls the earnings print \"relatively robust,\" praising the 20% revenue growth ex-FX and ex-Physical Stores with operating margins \"practically doubling\" to 7.4%.</li><li>Shares are <font color=\"green\">up 1.15%</font> premarket to $1,924.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454526-amazon-plus-1_6-percent-profit-doubles\" target=\"_blank\">Amazon +1.6% as profit doubles</a> (April 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454666-amazons-core-prime-getting-one-day-shipping-earnings-call\" target=\"_blank\">Amazon's core Prime getting one-day shipping - earnings call</a> (April 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454826\" data-linked=\"Analysts adjust Amazon targets after earnings smasher; shares up 1%\" data-tweet=\"$AMZN - Analysts adjust Amazon targets after earnings smasher; shares up 1% https://seekingalpha.com/news/3454826-analysts-adjust-amazon-targets-after-earnings-smasher-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3454826-analysts-adjust-amazon-targets-after-earnings-smasher-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454825\" data-ts=\"1556279463\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDX\" target=\"_blank\">FDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454825-fedex-cut-to-sell-ubs-sharesminus-1_8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FedEx cut to Sell at UBS; shares -1.8%</a></h4><ul><li>Investors are no doubt braced for \"pressure\" in FedEx's (NYSE:<a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a>) fiscal 2019 Q4, says UBS's Thomas Wadewitz, but expectations for fiscal 2020 remain too high.</li><li>He reminds that UPS's earnings this week showed more evidence of the softish macro environment.</li><li>Wadewitz: \"Muted free cash flow and long term concerns about Amazon are likely to continue weighing on FDX\u2019s valuation.\"</li><li>He downgrades to Sell from Neutral, with price target cut to $161 from $171.</li><li>Shares <font color=\"red\">down 1.8%</font> premarket to $185.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454825\" data-linked=\"FedEx cut to Sell at UBS; shares -1.8%\" data-tweet=\"$FDX - FedEx cut to Sell at UBS; shares -1.8% https://seekingalpha.com/news/3454825-fedex-cut-to-sell-ubs-sharesminus-1_8?source=tweet\" data-url=\"https://seekingalpha.com/news/3454825-fedex-cut-to-sell-ubs-sharesminus-1_8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454822\" data-ts=\"1556278753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTR\" target=\"_blank\">VTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454822-ventas-q1-store-cash-noi-rises-1_1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ventas Q1 same-store cash NOI rises 1.1%</a></h4><ul><li>Ventas (NYSE:<a href='https://seekingalpha.com/symbol/VTR' title='Ventas, Inc.'>VTR</a>) <a href=\"https://seekingalpha.com/pr/17489510-ventas-reports-2019-first-quarter-results\" target=\"_blank\">Q1 FFO per share</a> of 98 cents beats the average analyst estimate of 95 cents and improves from 96 cents in the year-ago period, mainly due to lower transaction costs.</li><li>Q1 total revenue of $942.9M slipped from $943.7M a year ago; rental income of $401.5M rose from $384.8M a year earlier.</li><li>Q1 same-store total property portfolio cash net operating income rose 1.1%. By segment:</li></ul><ol><li>Triple-Net +2.2%</li><li>Seniors housing operating portfolio -2.2%</li><li>Office +3.8%</li></ol><ul><li>Confirms 2019 guidance for FFO per share of $3.70-$3.82; normalized FFO per share of $3.75-$3.85; sees total company same-store cash NOI growth of 0%-1%.</li><li><a href=\"https://www.ventasreit.com/investor-relations\" target=\"_blank\">Conference call</a> at 10:00 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454776-ventas-beats-0_03-beats-revenue\" target=\"_blank\">Ventas beats by $0.03, beats on revenue</a> (April 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454822\" data-linked=\"Ventas Q1 same-store cash NOI rises 1.1%\" data-tweet=\"$VTR - Ventas Q1 same-store cash NOI rises 1.1% https://seekingalpha.com/news/3454822-ventas-q1-store-cash-noi-rises-1_1?source=tweet\" data-url=\"https://seekingalpha.com/news/3454822-ventas-q1-store-cash-noi-rises-1_1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454821\" data-ts=\"1556278719\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALV\" target=\"_blank\">ALV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454821-autolivplus-4-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Autoliv +4% post Q1 results</a></h4><ul><li>Autoliv (NYSE:<a href='https://seekingalpha.com/symbol/ALV' title='Autoliv, Inc.'>ALV</a>) reports organic sales rose 1.8% in <a href=\"https://seekingalpha.com/filing/4456484\" sasource=\"qp_sum_news_52\" target=\"_blank\">Q1</a>.</li><li>Sales by product: Airbags: $1.45B (+0.6%); Seatbelts: $726.3M (-9.4%).</li><li>Sales in Asia down 5.2% (-0.8% organic growth) to $750.7M.</li><li>Sales in America up 11.4% (+12.7% organic growth) to $743.1M.</li><li>Sales in Europe fell 13% (-4.9% organic growth) to $680.2M.</li><li>Gross profit rate deleveraged 310 bps to 17.4%.</li><li>SG&amp;A expense rate +20 bps to 4.7%</li><li>Adjusted operating margin declined 320 bps to 7.7%.</li><li><strong>FY2019 Guidance</strong>: Organic sales: ~+5%; Total sales: ~+3%; Adjusted operating margin continuing operations: ~10.5%; Tax rate: ~28%; Capex: Lower Y/Y.</li><li>ALV <font color=\"green\">+4.42%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454756-autoliv-misses-0_40-misses-revenue\" target=\"_blank\">Autoliv misses by $0.40, misses on revenue</a> (April 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454821\" data-linked=\"Autoliv +4% post Q1 results\" data-tweet=\"$ALV - Autoliv +4% post Q1 results https://seekingalpha.com/news/3454821-autolivplus-4-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3454821-autolivplus-4-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454820\" data-ts=\"1556278717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMC\" target=\"_blank\">AMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454820-amc-points-to-blowout-numbers-for-avengers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMC points to blowout numbers for Avengers</a></h4><ul> <li>AMC Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc.'>AMC</a>) says Disney's (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>) <em>Avengers: Endgame</em> will show about 58K times this weekend at the company's theaters to blow away the company's previous weekend screening record by more than 10K showings.</li>     <li>AMC has put approximately 10M seats on       sale between Thursday night's opening and Sunday night.</li><li>The Avengers movie set an all-time       record for Thursday night box office sales.</li>     <li>\"With wildly enthusiastic critic and fan reviews, interest in Avengers:Endgame has continued to grow beyond even the most optimistic       projections,\" notes AMC.</li><li>AMC  <font color=\"green\">+1.1%</font> premarket.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17489503-whatever-takes-amc-theatres-responds-unprecedented-demand-record-shattering-10-million-seats\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3454820\" data-linked=\"AMC points to blowout numbers for Avengers\" data-tweet=\"$AMC $AMC $DIS - AMC points to blowout numbers for Avengers https://seekingalpha.com/news/3454820-amc-points-to-blowout-numbers-for-avengers?source=tweet\" data-url=\"https://seekingalpha.com/news/3454820-amc-points-to-blowout-numbers-for-avengers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454818\" data-ts=\"1556278616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRK\" target=\"_blank\">MRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454818-mercks-keytruda-fails-to-beat-chemo-in-first-line-gastric-gej-cancer-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merck&#39;s Keytruda fails to beat chemo in first-line gastric/GEJ cancer study</a></h4><ul><li>Merck (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co., Inc.'>MRK</a>) reports <a href=\"https://seekingalpha.com/pr/17489228-merck-provides-update-phase-3-keynoteminus-062-trial-evaluating-keytruda-pembrolizumab\" target=\"_blank\">mixed results</a> from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02494583?term=keynote-062&amp;rank=1\" target=\"_blank\">KEYNOTE-062</a>, evaluating Keytruda (pembrolizumab), alone and in combination with chemo, in patients with advanced gastric or gastroesophageal junction &#40;GEJ&#41; adenocarcinoma in a first-line setting.</li><li>In the monotherapy arm, Keytruda showed non-inferiority (no worse than) to standard-of-care chemo (cisplatin and either 5-fluorouracil or capecitabine) in terms of a survival benefit in the intent-to-treat population, but apparently did not in terms of progression-free survival &#40;PFS&#41;.</li><li>In the combo arm, Keytruda failed to demonstrate a treatment benefit compared to chemo + placebo in terms of survival or PFS.</li><li>A earlier Phase 3, KEYNOTE-061, assessing Keytruda for the second-line treatment of the same patient population also <a href=\"https://seekingalpha.com/news/3318455-mercks-keytruda-flunks-late-stage-study-second-line-gastric-cancer\" target=\"_blank\">failed to demonstrate</a> a treatment effect compared to chemo.</li><li>Keytruda is currently approved in the U.S. for the third-line treatment of PD-L1-expressing gastric or GEJ cancer.</li><li>Shares are down a fraction premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3454818\" data-linked=\"Merck&#39;s Keytruda fails to beat chemo in first-line gastric/GEJ cancer study\" data-tweet=\"$MRK - Merck&#39;s Keytruda fails to beat chemo in first-line gastric/GEJ cancer study https://seekingalpha.com/news/3454818-mercks-keytruda-fails-to-beat-chemo-in-first-line-gastric-gej-cancer-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3454818-mercks-keytruda-fails-to-beat-chemo-in-first-line-gastric-gej-cancer-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454817\" data-ts=\"1556278503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454817-western-digital-gets-two-notch-downgrade-wdcminus-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Digital gets two-notch downgrade; WDC -3%</a></h4><ul><li>Baird downgrades Western Digital (NASDAQ:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) from Outperform to Underperform and cuts the target by $10 to $40.</li><li>Analyst Tristan Gerra cites continued deterioration in NAND fundamentals that's \"characterized by an expected continuation of double digit price declines this quarter and very high inventories.\"</li><li>Gerra notes that an H2 seasonal improvement in NAND doesn't mean it's the cycle bottom.</li><li>The analyst notes that Intel's earnings report yesterday confirmed the degradation of NAND trends.</li><li>WDC shares are <font color=\"red\">down 3.2%</font> pre-market to $51.25.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454563-micron-nvidia-sink-intel-slashes-outlook\" target=\"_blank\">Micron, Nvidia sink as Intel slashes outlook</a> (April 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454577-intel-minus-6-percent-cut-2019-guidance\" target=\"_blank\">Intel -6% on cut 2019 guidance</a> (April 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454817\" data-linked=\"Western Digital gets two-notch downgrade; WDC -3%\" data-tweet=\"$WDC - Western Digital gets two-notch downgrade; WDC -3% https://seekingalpha.com/news/3454817-western-digital-gets-two-notch-downgrade-wdcminus-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3454817-western-digital-gets-two-notch-downgrade-wdcminus-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454813\" data-ts=\"1556278376\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMAX\" target=\"_blank\">IMAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454813-imax-beats-0_01-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IMAX beats by $0.01, misses on revenue</a></h4><ul><li>IMAX (NYSE:<a href='https://seekingalpha.com/symbol/IMAX' title='IMAX Corporation'>IMAX</a>): Q1 Non-GAAP EPS of $0.18 <span style=\"color:green\">beats by $0.01</span>; GAAP EPS of $0.20.</li><li>Revenue of $80.2M (-5.6% Y/Y) <font color=\"red\">misses by $1.09M</font>.</li><li>Shares <font color=\"green\">+1.84%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17489594-imax-corporation-reports-first-quarter-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3454813\" data-linked=\"IMAX beats by $0.01, misses on revenue\" data-tweet=\"$IMAX - IMAX beats by $0.01, misses on revenue https://seekingalpha.com/news/3454813-imax-beats-0_01-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3454813-imax-beats-0_01-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454810\" data-ts=\"1556278296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454810-american-airlines-beats-0_02-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Airlines beats by $0.02, misses on revenue</a></h4><ul><li>American Airlines (NASDAQ:<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group Inc.'>AAL</a>): Q1 Non-GAAP EPS of $0.52 <span style=\"color:green\">beats by $0.02</span>; GAAP EPS of $0.41.</li><li>Revenue of $10.58B (+1.7% Y/Y) <font color=\"red\">misses by $30M</font>.</li><li>Shares <font color=\"green\">+1.77%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17489591-american-airlines-group-reports-first-quarter-2019-profit\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3454810\" data-linked=\"American Airlines beats by $0.02, misses on revenue\" data-tweet=\"$AAL - American Airlines beats by $0.02, misses on revenue https://seekingalpha.com/news/3454810-american-airlines-beats-0_02-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3454810-american-airlines-beats-0_02-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3454800\" data-ts=\"1556277333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFLY\" target=\"_blank\">SFLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3454800-shutterflyplus-3-on-beats-fy-eps-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shutterfly +3% on beats, FY EPS raise</a></h4><ul><li>Shutterfly (NASDAQ:<a href='https://seekingalpha.com/symbol/SFLY' title='Shutterfly, Inc.'>SFLY</a>) +3.1% after yesterday's Q1 beats with 63% Y/Y revenue growth. Upside Q2 guidance has revenue from $469M to $479M, which beats the $473.67 consensus at the midpoint.</li><li>The FY19 outlook reaffirms $2.13B to $2.21B (beats $2.15B at midpoint) and raises EPS to $0.61 to $1.11 from $0.55 to $1.06 (misses $0.89 consensus at midpoint).</li><li>The company says it's still considering strategic alternatives and has no update at this time. Earlier this week, Bloomberg sources said Apollo and Cerberus were <a href=\"https://seekingalpha.com/news/3453692-shutterfly-spikes-m-headlines\" target=\"_blank\">considering bids</a> for the company.</li><li>Analyst action: Raymond James raises Shutterfly from Market Perform to Outperform with a $56 price target, implying a 33% upside.</li><li><a href=\"https://seekingalpha.com/pr/17488881-shutterfly-announces-first-quarter-2019-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3454479-shutterfly-beats-0_10-beats-revenue\" target=\"_blank\">Shutterfly beats by $0.10, beats on revenue</a> (April 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3454800\" data-linked=\"Shutterfly +3% on beats, FY EPS raise\" data-tweet=\"$SFLY - Shutterfly +3% on beats, FY EPS raise https://seekingalpha.com/news/3454800-shutterflyplus-3-on-beats-fy-eps-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3454800-shutterflyplus-3-on-beats-fy-eps-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}